With AI and big data tokens experiencing renewed capital rotation, Injective is pumping. In fact, after successfully holding $5.3, Injective finally reclaimed and flipped $6 resistance.
In doing so, the altcoin jumped to a three-month high of $6.7. As of this writing, Injective traded around $6.39, marking a 13.15% surge on the daily charts.
The price hike was supported by a 172% surge in trading volume, reflecting increased capital deployment and market activity.
Injective’s staked supply hit ATH Although capital rotation into AI coins is a major sector-wide boost, Injective is experiencing its own motivating factors. For starters, altcoin’s strong jump seems driven by rising demand from stakers and reduced supply.
As such, Injective reached a new all-time high in total tokens staked. Reportedly, over 58.8 million INJ tokens worth approximately $370 million are now staked on-chain.
Source: Injective This jump in the amount of INJ staked made Injective one of the leading L1 chains by total staked supply.
With almost 59% of the supply already staked, tokens available for immediate selling have plunged extensively, with only 34 million INJ in circulation.
Such a significant drop in supply has increased scarcity, which often strengthens tokens and leads to more gains.
INJ goes live on Robinhoodcrypto Additionally, INJ went live on Robinhood Crypto, thus expanding Injective’s user base. With the integration, Injective posited that millions of users will now easily access the INJ ecosystem for its on-chain markets, RWAs, and tokenized stocks.
As Injective expands its market reach, the network activity is growing, especially driven by real-world asset tokenization. As a result, Injective is one of the leading chains in tokenization.
The chain has now tokenized over $1 billion in residential mortgage records. Also, Injective seeks to migrate over $10 billion in assets in the coming months.
Can the rally continue? With market supply reducing, Injective’s upside pressure is emerging as dominant. For instance, INJ currently sits above the least squares moving averages, a clear sign of this bullish dominance.
Source: Tradingview At the same time, the altcoins’ Relative Strength Index (RSI) has held on an upward trajectory for four days, rising to 70. At these levels, RSI suggests bulls have total dominance of the market.
Often, such a setup has preceded some gains on the price charts. Therefore, if current conditions persist, Injective will close above $6.7 and eye a move past $7.
Source: CoinGlass However, the recent price hike attracted profit-taking, which presents a pullback risk. Since INJ reclaimed $5 four days ago, Netflow has held positive, rising to $1.8 million.
Increased profit taking explains why the upside is slowing down, and if it continues, a drop below $6 will follow, with $5.6 as support.
Final Summary INJ soared 13%, flipped $6 resistance, and climbed to a three-month high of $6.7 before a slight retrace. Injective reached a new ATH in INJ staked, with $58.8 million worth approximately $370 million staked on-chain.
Robinhood US now supports INJ transfers. You can trade USD for INJ, send it from Robinhood, and receive it in a self custody wallet on Injective.
The direct route uses native INJ. No bridge is required. Robinhood lists INJ among its supported transfer assets and lists one network confirmation for INJ deposits.
Keplr is the primary wallet in this tutorial because it displays the native Injective address that begins with
The public Robinhood US page for buying Injective.Trade INJ on Robinhood, copy the native Injective address from any supported crypto wallet, and submit the transfer.What You NeedTo complete this tutorial, you need:
A verified Robinhood Crypto accountA Keplr or Metamask wallet with Injective availableEnough buying power to purchase INJRobinhood's transfer verification can take up to five business days.
Step 1. Copy your Injective address from KeplrOpen Keplr and select Injective from the network list.
Copy the address shown for the account. A native Injective address begins with
Check the first and final characters after copying it.
Copy the native Injective address from Keplr.Step 2. Trade USD for INJ on RobinhoodOpen Robinhood and search for Injective or INJ.
Select Buy. Enter the amount, choose the available order option, review the purchase, and submit it.
Wait for INJ to appear as an available balance. Unsettled funding and transfer limits can restrict the amount you can send.
Trade INJ through Robinhood US.Step 3. Send INJ to KeplrOpen the INJ detail page in Robinhood and select Send.
Paste the native Injective address copied from Keplr. Enter the amount you want to send.
Confirm these fields before continuing.
The asset is INJ.The destination is the Keplr address you copied.The address begins with The displayed network matches Injective.The amount leaves enough room for the estimated network fee.Start with a small test transfer. Robinhood displays the network fee before submission and does not add its own transfer fee.
Select Review. Compare the address one more time, then select Submit.
Send native INJ from Robinhood US to Keplr.Step 4. Confirm the INJ balance on InjectiveOpen the Robinhood transfer status and copy the transaction ID. Refresh Keplr and confirm the INJ balance. You can also check the transaction ID or recipient address in InjScan.
Robinhood lists one confirmation for INJ deposits, with an estimated network time of about one second. Its account review can add time.
Robinhood shows the transfer while it moves onchain.Confirm the received INJ balance in Keplr.Keplr displays the native Injective address used in this tutorial. It begins with
MetaMask displays an EVM address that begins with
If INJ sending is unavailable in your accountCheck for a verification prompt, funding hold, transfer limit, or network maintenance. Wait when Robinhood identifies a temporary restriction.
Use USDC as a fallback only when the direct route is not available to your account.
Buy or hold USDC in Robinhood.Open MetaMask on Ethereum and copy its Send USDC from Robinhood over Ethereum to that MetaMask address.Add ETH to MetaMask for the bridge transaction fee.Open the Injective CCTP Bridge.Set Ethereum as the source and Injective as the destination.Approve USDC and confirm the transfer in MetaMask.Confirm the native USDC balance on Injective.
The source selected in Robinhood must match the bridge source. This Ethereum route produces native USDC on Injective.
USDC trading is unavailable through Robinhood Crypto in Texas. Check the live asset and transfer controls before funding this fallback.
Common errorsThe Send button is missingComplete Robinhood's crypto transfer verification. Then check for a funding hold, account restriction, transfer limit, or network maintenance notice.
Robinhood rejects the addressReturn to Keplr and copy the address under Injective. Confirm that it begins with
The full balance is not availableRecent bank funding can remain unsettled. Open Account, Menu, then Crypto to view the current transfer limit.
Keplr does not show the balanceRefresh Keplr and select Injective. Check the recipient and transaction status in InjScan.
USDC reached MetaMask but cannot moveConfirm that the USDC is on Ethereum and that MetaMask has ETH for the network fee. Set Ethereum as the source inside the CCTP Bridge.
Regional availabilityRobinhood US and Robinhood Europe support direct INJ transfers. Robinhood Europe documents native
Robinhood UK does not support crypto deposits or withdrawals to external wallets through its current Bitstamp UK integration. UK users need an exchange that supports outbound native INJ.
Check the live transfer screen before buying.
Move INJ onchainYour INJ is ready to use once Keplr shows the balance on Injective. Connect Keplr to Injective Hub to access staking, governance, and applications across the network.
About InjectiveInjective is the first blockchain purpose-built for finance, enabling users, institutions, and AI agents to trade, tokenize, and transact at scale. Proudly made in America, Injective provides foundational blockchain infrastructure for global markets, with embedded financial primitives spanning stablecoins, real-world assets, payments, and programmable perpetuals through a unified onchain engine. Injective is used by Fortune 500 companies, banks, fintechs, and governments to power an open economy where any asset can be accessed anytime, from anywhere. Builders can deploy across multiple virtual machines like WASM and EVM, connect to native financial modules, and launch markets with deep liquidity from day one. INJ is the native token powering the rapidly growing Injective ecosystem and the new internet economy.
Kraken Opens a Direct USDC Bridge to InjectiveKraken has added native USDC deposits and withdrawals on Injective, giving users a direct path between the exchange and the network. Capital can now flow between Kraken and Injective without routing through another blockchain or relying on wrapped tokens.
The integration removes a step that previously added friction for traders moving stablecoins onchain. Kraken users can withdraw USDC directly to an Injective address and deposit it back through the same network, streamlining access to Injective's onchain markets.
Why Native USDC Matters for InjectiveThe Kraken integration builds on a broader shift for Injective that began in May 2026. , giving the network a regulated dollar asset issued directly by Circle rather than through a bridge.
Sources:
Kraken Blog: USDC deposits and withdrawals now available on Injective
Injective Blog: Native USDC and CCTP live on Injective
Circle Blog: USDC and CCTP are coming to Injective
Nebius just auctioned its first Blackwell capacity above any price it has ever charged, and management says it could sell all of 2027 right now but is choosing not to. Whether that restraint makes the stock a buy at these…
At its current $243.88 share price, Nebius Group (NASDAQ:NBIS | NBIS Price Prediction) looks compelling for investors focused on the next leg of AI compute pricing power. Shares have run hard, but management’s most recent disclosures suggest the pricing story is only beginning to inflect.
Nebius operates a full-stack AI cloud platform spanning compute, storage, managed services, and inference, with its Token Factory targeting open-model deployment. NVIDIA‘s (NASDAQ:NVDA) strategic equity investment and Exemplar Cloud designation place Nebius inside the reference architecture for Blackwell and Vera Rubin builds, alongside anchor contracts with Meta Platforms (NASDAQ:META) and Microsoft (NASDAQ:MSFT). The stock has climbed from $88.62 at the February 2026 filing to today’s level as capacity milestones and record run-rate revenue have landed in sequence.
Why Full-Capacity Pricing Is the Real Story The Q2 earnings call reframed the thesis. CEO Arkady Volozh said Nebius “could sell today our entire 2027 capacity on these terms if we wanted to”, but is deliberately holding capacity back for premium short-duration deals. Its first Blackwell capacity auction cleared 15% above the highest price the company had ever charged, and short-duration contracts are being negotiated at $40 million to $50 million per megawatt versus $20 million to $25 million on mid-term deals.
Q2 revenue reached $582.3M, up 454% YoY, with group adjusted EBITDA of $236 million at a 41% margin. Management raised contracted power to 5 gigawatts by year-end, RPO stands at $37.5B, and ARR guidance of $7B to $9B by year-end 2026 was reaffirmed. Four landmark Q2 deals averaged more than a billion dollars each.
Where the Bear Argument Bites Hardest The build is capital-intensive at unprecedented scale. FY 2026 capex guidance sits at $20 billion to $25 billion, and Q2 interest expense surged to $95 million from roughly $4.8 million a year prior. Convertible debt carries $8.5B at cost but $20.8B in fair value, embedding real dilution risk. The ATM program placed 12.7 million Class A shares at an average of $224, with 12.3 million shares still authorized.
Three customers accounted for 24%, 21%, and 14% of Q2 revenue. GAAP net loss came in at $190.4M despite the EBITDA inflection, and revenue missed consensus in three of the four quarters preceding the Q2 beat. FY 2026 EPS consensus has been cut to -$2.5183 from -$1.6233 ninety days ago.
Reasons Some Investors Would Rather Sit Tight NBIS is up 191.36% YTD versus 12.32% for the S&P 500, and trades at roughly 45x forward earnings and 45x trailing sales. Much of the ARR ramp, 5 GW power target, and 40% EBITDA margin outlook is arguably discounted at these levels. Execution on Pennsylvania (1.2 GW), Finland (310MW), and Missouri (1.2 GW) sites still has to land on schedule, and every one of those gigawatts has to be powered and cooled by somebody (we rounded up seven suppliers doing exactly that work in a free AI infrastructure report).
Patient investors could wait for Q3 revenue to validate the $906.6M consensus and Q4 to test the ARR range. Cost of patience is real if auction pricing keeps climbing, and so is the cost of adding at fresh 52-week highs.
What the Data Actually Says Nebius trades at $243.88 with a market cap near $61.5B and forward P/E near 45. The 4-analyst mean target of $286.69 sits above the current share price, though price targets are one data point and not a guarantee. The ratings breakdown:
Strong Buy: 1 Buy: 2 Hold: 1 Sell: 0 Recent performance separates NBIS from the market: up 22.22% in one week, 29.74% over one month, 191.36% YTD, and 280.71% over one year. SPY returned 0.55% for the week, -0.94% over one month, and 12.32% YTD. FY 2026 revenue consensus sits at $3.34B across 17 analysts, rising to roughly $11.97B for FY 2027.
Verdict on Nebius at Current Levels At $243.88, the setup for Nebius Group looks constructive. Here is why.
Q2’s pricing signal is the pivotal development. When a supplier can auction Blackwell capacity 15% above its prior high and command $40 million to $50 million per megawatt on short-duration deals, ARR guidance of $7B to $9B reads as a floor built on mid-term contracted pricing that management is deliberately leaving room to exceed.
Three near-term catalysts drive the path higher: Q3 and Q4 2026 results validating ARR against the $906.6M and $1.45B consensus prints, an initial 2027 revenue guide from management, and additional asset-backed debt at SOFR plus 250 basis points that eases reliance on dilutive equity. The July $775M facility is the template. Scaling it makes the convertible overhang more manageable.
Risk/reward at $243.88 demands careful sizing after a 191% YTD run. The thesis breaks if Q3 revenue misses the $906.6M bar, if the 5 GW power target slips, or if auction pricing rolls over. Short of those signals, the setup favors owning the operator that keeps proving pricing power in a supply-constrained market.
Contact [email protected] for any questions or corrections.
PARIS & HERNDON, Va.--(BUSINESS WIRE)---- $BKSY #analytics--BlackSky named exclusive provider of very high-resolution EO constellation for initiative to build world's largest AI infrastructure in space.
Key Takeaways LHX secures its largest PAC-3 propulsion contract to date, covering key interceptor components.LHX is expanding PAC-3 MSE manufacturing capacity with two new Camden facilities expected in 2027.LHX's Missile Solutions revenues rose 14%, while its contractual backlog reached $10.5B. L3Harris Technologies, Inc. (LHX - Free Report) is expanding its position in missile defense propulsion following a new $4.7 billion contract from Lockheed Martin. Announced on Sept. 8, 2026, the seven-year undefinitized contract award covers propulsion systems for the PAC-3 Missile Segment Enhancement (“MSE”) interceptor. The award is L3Harris’ largest PAC-3 propulsion contract to date and provides visibility into production activity.
The contract covers production of the PAC-3 MSE’s two-pulse solid rocket motor, Lethality Enhancer and Attitude Control Motors. These propulsion components support the interceptor and could sustain production as demand for missile-defense capabilities increases. The agreement builds on the procurement framework established among L3Harris, the Department of War and Lockheed Martin.
L3Harris is increasing its manufacturing capacity to support higher PAC-3 MSE volumes. The company broke ground in June on two new facilities at its Camden, AR, site, with both expected to become operational in 2027. The facilities are designed to increase production, improve throughput and modernize solid rocket motor manufacturing. These investments could help L3Harris accommodate higher demand.
The PAC-3 award adds to the momentum in L3Harris’ Missile Solutions business. Second-quarter revenues increased 14% year over year to $1.05 billion, driven by higher Propulsion Systems production and development volumes across missile and munitions programs. The segment ended the quarter with $10.5 billion in the contractual backlog, providing a base of future work. The new PAC-3 award could strengthen long-term revenue visibility as the company expands its production footprint.
Companies Expanding Missile Defense ProductionRising demand for missile-defense capabilities is encouraging defense contractors to increase production of interceptors, propulsion systems and related technologies. Lockheed Martin Corporation (LMT - Free Report) and RTX Corporation (RTX - Free Report) are two major U.S. defense companies positioned across the missile-defense supply chain.
Lockheed Martin is the prime contractor for the PAC-3 MSE interceptor, directly benefiting from higher production of the system supported by L3Harris’ propulsion award. This creates growth opportunities across both the interceptor and propulsion supply chains.
RTX develops missile-defense systems and interceptors for the Patriot air-defense architecture. Its exposure to these programs provides an avenue to benefit from continued investment in expanding U.S. air- and missile-defense capabilities.
Earnings Estimates for LHXThe Zacks Consensus Estimate for 2026 and 2027 earnings per share suggests year-over-year growth of 9.79% and 14.44%, respectively.
Image Source: Zacks Investment Research
LHX Stock Is Trading at a DiscountLHX is trading at a discount relative to the industry, with a forward 12-month price-to-sales of 1.93X compared with the industry average of 2.36X.
Image Source: Zacks Investment Research
LHX Stock Price PerformanceOver the past year, LHX shares have fallen 7.2% compared with the industry’s 7.7% decline.
Image Source: Zacks Investment Research
LHX’s Zacks RankLHX currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.8% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Expand Energy (EXE - Free Report) Expand Energy Corporation is a leading U.S.-based natural gas producer formed through the merger of Chesapeake Energy Corporation and Southwestern Energy Company. The all-stock merger, completed on Oct. 1, 2024, established a premier natural gas-focused company with leading positions in the Haynesville and Appalachian basins, premium drilling inventory and proximity to key liquefied natural gas (LNG) and domestic demand markets. The merger strengthened scale, operational efficiencies and financial resilience, supporting an investment-grade balance sheet, enhanced credit capacity and significant shareholder returns, while positioning the company to meet growing global energy demand.
EXE is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Additionally, the company could be a top pick for growth investors. EXE has a Growth Style Score of B, forecasting year-over-year earnings growth of 44.9% for the current fiscal year.
Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.37 to $8.84 per share. EXE boasts an average earnings surprise of +7.2%.
With a solid Zacks Rank and top-tier Growth and VGM Style Scores, EXE should be on investors' short list.
Míru „utrpení“ akciového trhu bychom mohli na té základní úrovni měřit tím, zda ceny rostou, nebo klesají (a o kolik). Z určitého pohledu by ale byly lepším měřítkem valuace – pokud jsou historicky vysoko, trh rozhodně netrpí, i když může zrovna oslabovat. A naopak. Dnes se ale podíváme na „utrpení“ jinde – ne na Wall Street ale na tzv. Main Street. Včetně malých firem. Co o celé ekonomice a možná nakonec i akciovém trhu říká výsledný obrázek?
Obecně se dá chápat, že čím, vyšší inflace a čím vyšší nezaměstnanost, o to se lidem žije ekonomicky hůře. Součet těchto dvou proměnných je tak používán jako tzv. index utrpení. Jako měřítko problémů přitom začíná kulhat třeba v dezinflačním, nebo deflačním útlumu. Nebo ve chvíli, kdy každý další procentní bod inflace není pro lidi stejně problematický, jako každý další bod nezaměstnanosti. Berme tedy tento index s rezervou a podívejme se na následující graf, který ukazuje jeho konkrétní hodnoty od roku 1990:
Zdroj: X
Po roce 2020 se hodnota zmíněného indexu prudce zvedla a stále se pohybuje znatelně nad hodnotami z období po roce 2015. Ovšem po roce 2000 až do roku 2015 byla situace celkově mnohem horší než v posledních letech. Přitom mám pocit (a skutečně jen pocit), že míra ekonomické nespokojenosti a tenzí je nyní v USA (a nejen tam) výrazně vyšší, než před po řadu let po roce 2000. Což by samozřejmě bylo na hlubší úvahu, už ne z čistě ekonomického pohledu. Zde bych ještě chtěl poukázat na následující:
Pro malé firmy je podle posledního průzkumu NFIB největším problémem inflace a nedaleko na ní zdanění. Pak s určitým odstupem kvalita práce a už s docela velkým odstupem vládní regulace, náklady práce a další. Když se přitom podíváme na výsledky podobných průzkumů mezi velkými společnostmi obchodovanými na americkém akciovém trhu, centrum pozornosti je jinde – směřuje na umělou inteligenci. Tedy její příležitosti a rizika. K tomu jsou třeba v průzkumu PWC ze srpna letošního roku zmiňována cla a geopolitická nejistota. A tím se dostávám k obrázku, který jsem tu ukazoval v pondělí. Navzdory jeho nadpisu nejde o rizikovou prémii akciového trhu ale určitý celkový ukazatel optimismu na akciích (mix prémie a růstových očekávání):
Zdroj: X
Připomínáme si tedy, že míra optimismu je nyní na americkém trhu již nějakou dobu hodně vysoká – rozdíl mezi obráceným PE a (reálnými) desetiletými výnosy dluhopisů je nyní jen na 2,8 %. Což znamená, že růstová očekávání jsou hodně vysoko a cena za riziko na akciích hodně nízko (celkový optimismus vysoko). Optimističtější byli investoři jen kolem vrcholu internetové bubliny. Porovnání s prvním grafem pak ukazuje, že:
Pesimismus na Main i Wall Street rostl cca do roku 2011, na akciích pak ale soustavně klesal. Ale u indexu utrpení bylo dosaženo nejnižších úrovní kolem roku 2019. A pak se začal zase zvedat. Což by se dalo shrnout tak, že po tomto roce se začala tvořit občas zmiňovaná ekonomika tvaru K. U umělé inteligence se přitom dá uvažovat o scénářích, které by toto „K“ ještě posilovaly. Ale dnes jsme mimo jiné z popsané perspektivy viděli, že jeho základy byly položeny už před lety. Co s ním? Výběr více, či méně (či vůbec) elegantních řešení je docela velký, ale to už je téma samo o sobě. Jen jedno číslo nakonec: Nejbohatší 1 % domácností vlastní v USA 47 % akciového trhu.
Includes Monday Night Hockey and over 100 additional matchups
The best sports entertainment experience now includes more games than ever before
TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Rogers Communications today announced the addition of exclusive Sportsnet+ content to TV packages at no additional cost, including over 150 NHL games.
“Rogers Xfinity brings sports fans more NHL games than ever before and the best seat in the house,” said Bret Leech, President, Residential. “By adding content exclusive to Sportsnet+ into our TV packages, we’re bringing more value to Rogers Xfinity customers and making it easier for them to seamlessly catch all the action with our world-class platform.”
Starting September 29, Rogers is adding three new digital channels with the exclusive content to Rogers Xfinity TV packages that have Sportsnet, making it the best place for hockey fans to catch NHL action all season long. Customers do not need to take any action and can simply use their award-winning voice remote to find NHL games, including Monday Night Hockey and over 100 additional matchups along with other exclusive sports content.
Rogers Xfinity TV customers with Sportsnet in their package now have more reasons to watch with the exclusive content in the Sportsnet+ add-on package, valued at $12.99 per month, included automatically.
For more information on Rogers Xfinity TV, visit rogers.com
About Rogers Communications Inc.
Rogers is Canada’s communications, sports and entertainment company, and its shares are publicly traded on the Toronto Stock Exchange (TSX: RCI.A and RCI.B) and on the New York Stock Exchange (NYSE: RCI). For more information, please visit rogers.com or about.rogers.com/investor-relations.
For more information:
Rogers Communications [email protected]
1-844-226-1338
Nationwide event on Saturday, Sept. 12, will showcase locally made goods, with the first 20 customers at each store receiving a limited-edition tote designed by an FFA member
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Tractor Supply Company (NASDAQ: TSCO), the largest rural lifestyle retailer in the United States, is celebrating the people who grow, make, bake and create in communities across the country with its nationwide Harvest Fest on Saturday, Sept. 12. From 10 a.m. to 2 p.m. local time, participating Tractor Supply stores will welcome local farmers, makers, bakers and artisans to sell their goods in a farmers market-style event for the community.
“Out Here, our neighbors grow, make, bake and build incredible things every single day,” said Eric Jackson, Vice President of Marketing at Tractor Supply. “Harvest Fest is an opportunity to celebrate those talents and support local entrepreneurs. Many of these makers shop our aisles every week, so it’s a privilege to showcase their hard work and celebrate the communities that make Life Out Here so special.”
Adding a special FFA connection to this year's Harvest Fest, the first 20 customers at each store will receive a free limited-edition tote designed by FFA member Mia Harman of Bonners Ferry, Idaho. In April, Tractor Supply hosted a design contest for FFA members, inviting students to submit a bag design for the chance to receive a $250 Tractor Supply gift card as well as a $1,000 gift card for their FFA chapter to use toward funding future projects. Mia’s winning design captures the essence of life on the farm with livestock, produce and an idyllic barn, and is centered around the phrase “Rooted in Ag.”
Popular Harvest Fest items include handmade crafts such as birdhouses, wind chimes, jewelry, crocheted items and custom-forged knives; homemade cakes, bread, hot sauce and popcorn; local honey, canned goods, fresh produce and so much more. After attendees fill their totes, they can browse Tractor Supply’s extensive lineup of seasonal farm-inspired accents and Halloween costumes and décor. Customers will also receive a coupon for $1 off Pepsi products with a $5 spend, while supplies last.
To further support FFA members, customers can donate to Tractor Supply’s FFA Future Leaders fundraiser at checkout in-store or online until Sunday, Sept. 20. Donations fund scholarships for FFA members pursuing studies in skilled trades or agriculture-related fields.
For details on your community’s Harvest Fest event, visit your local Tractor Supply store or find a location at TractorSupply.com/store-locator.
About Tractor Supply Company
For more than 85 years, Tractor Supply Company (NASDAQ: TSCO) has been passionate about serving the needs of recreational farmers, ranchers, homeowners, gardeners, pet enthusiasts and all those who enjoy living Life Out Here. Tractor Supply is the largest rural lifestyle retailer in the U.S., ranking 290 on the Fortune 500. The Company’s more than 54,000 Team Members are known for delivering legendary service and helping customers pursue their passions, whether that means being closer to the land, taking care of animals or living a hands-on, DIY lifestyle. In store and online, Tractor Supply provides what customers need – anytime, anywhere, any way they choose at the low prices they deserve.
As part of the Company’s commitment to caring for animals of all kinds, Tractor Supply is proud to include Petsense by Tractor Supply, a pet specialty retailer, Allivet, a leading online pet and animal pharmacy, and VIP Petcare, the largest provider of mobile veterinary care in the U.S., in its family of brands. Together, Tractor Supply is able to provide comprehensive solutions for pet care, livestock wellness and rural living, ensuring customers and their animals thrive. From its stores to the customer’s doorstep, Tractor Supply is here to serve and support Life Out Here.
As of June 27, 2026, the Company operated 2,463 Tractor Supply stores in 49 states and 209 Petsense by Tractor Supply stores in 23 states. For more information, visit www.tractorsupply.com and www.Petsense.com.
Tractor Supply Company (TSCO) Barclays 19th Annual Global Consumer Staples Conference September 9, 2026 8:15 AM EDT
Company Participants
Harry Lawton - President, CEO & Director
Kurt Barton - Executive VP, CFO & Treasurer
Conference Call Participants
Seth Sigman - Barclays Bank PLC, Research Division
Presentation
Seth Sigman
Barclays Bank PLC, Research Division
All right. Good morning, everybody. Thanks for coming. My name is Seth Sigman. I am the U.S. hardline, broadline food retail analyst here at Barclays. My pleasure to have the management team of Tractor Supply with us today, Hal Lawton, President and CEO; Kurt Barton, EVP, CFO and Treasurer. We also have Mary Winn Pilkington, SVP, IR and Public Relations, in the audience somewhere. I don't know -- there she is. Perfect.
Interesting time for Tractor Supply, a lot we want to cover today. I guess, first for you, Hal, to kick it off, high level, Tractor Supply has discussed a number of external drivers influencing the business over the last few quarters. We'll also talk a lot about the company-specific opportunities. But if we could just level set here, maybe frame down the top-down view of the business right now. What are some of the key factors, key end market dynamics that you're seeing? And what are you most and least optimistic about as we sort of look out?
Question-and-Answer Session
Harry Lawton
President, CEO & Director
Yes. Good morning, everyone, and thanks for joining us today, and thanks, Seth, for the question, and thanks for having us here.
As Seth mentioned, kind of, if we start at the high level, Tractor Supply participates in a large market. We estimate our market to be $225 billion in size. We're the largest player in our market at around 7% to 8% market share. If you just kind of look at it over multi-decades, it's a very attractive
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.8% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Equinor (EQNR - Free Report) Headquartered in Stavanger, Norway, Equinor ASA is an integrated energy company, with operations across 30 countries. The company is the largest supplier of pipeline gas to Europe. Equinor is also a leading seller of crude oil. The company has expanded upstream operations outside conventional offshore resources to shale oil and gas plays. At 2025-end, the company had estimated proved reserves of 5,183 million barrels of oil equivalent (Boe), compared with 5,571 million Boe at 2024-end. The reserve replacement ratio was 48% in 2025.
EQNR is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 8.56; value investors should take notice.
Three analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.32 to $5.07 per share. EQNR also boasts an average earnings surprise of +10.5%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, EQNR should be on investors' short list.
Bitmine just loaded up on nearly 30,000 more Ethereum tokens, pushing its treasury toward a staggering size that rivals its entire stock market value. But the real question is whether this buying spree moves the price of ETH or simply…
Bitmine Immersion Technologies (NYSE:BMNR | BMNR Price Prediction) added 28,086 Ethereum over the past week, lifting its Ethereum (CRYPTO:ETH) treasury to 5.93 million tokens and its total crypto and cash holdings to $15.7 billion as of September 8, 2026. With Ethereum trading around $2,500, the company’s ETH portfolio alone is worth nearly $15 billion, while the larger figure also includes cash and other crypto assets.
BMNR is trading at $24.97, up 35.49% over the past month but still down 40.8% over the past year. At roughly $15.06 billion, its market value is now close to its crypto holdings. If Bitmine keeps buying Ethereum at this pace, does the buying eventually push ETH higher, or does the bigger impact show up in BMNR’s stock instead?
How Bitmine’s Treasury Model Works
A crypto treasury company raises money in the public markets and uses it to buy digital assets for its balance sheet. That makes the stock a leveraged bet on the coin because shareholders are exposed to both the treasury’s value and the underlying asset’s performance. When Ethereum rises, the value of Bitmine’s holdings rises with it, which can push BMNR higher. When ETH falls, the same exposure works in reverse, and the stock can take a bigger hit.
The way Bitmine funds its purchases also affects what existing shareholders own. If the company uses cash already on its balance sheet, shareholders keep the same claim on the treasury. If Bitmine issues new shares to raise money for more ETH, the treasury gets bigger, but so does the number of shares competing for it. The strategy only works for existing shareholders if the additional ETH adds enough value to offset that dilution.
Bitmine’s mining operation is based at its Silverton, Texas facility, where it runs 4,640 machines and generates roughly $1.2 million a quarter. The company has since shifted its focus heavily toward Ethereum, with MAVAN, its Made in America Validator Network, launching on March 25, 2026. The platform allows Bitmine to stake its ETH and earn fees from the treasury, with Tom Lee estimating that fully staking the holdings could generate about $374 million a year.
Bitmine’s Buying Is Not the Same as Ethereum Demand
Bitmine holding 5.93 million ETH removes a meaningful amount of supply from the market, which can support the price at the margin if the company continues accumulating. But one company buying heavily does not prove that demand for Ethereum is spreading across the wider market. ETH still depends on broader capital flows, ETF activity, and overall liquidity, with Bitmine’s purchases representing just one part of that picture.
There is also a limit to what can be inferred from the size of Bitmine’s treasury. The company is accumulating ETH for its own balance sheet and staking strategy, but that does not mean other businesses are preparing to use ETH for payments, settlement, or network fees.
The release does not identify a settlement asset, partner network, or fee-sharing arrangement that would create additional demand for ETH, so Bitmine’s buying should be viewed as one large buyer accumulating the asset, rather than evidence of a broader corporate adoption trend.
Tom Lee’s $6,000 Ether Forecast Comes With a Conflict to Consider
Tom Lee said on August 28, 2026, that Ethereum could reach $6,000 by the end of the year if Bitcoin climbs to $150,000 and the ETH-to-BTC ratio rises from around 0.03 to 0.04. However, Lee’s work at Fundstrat and his role at Bitmine both stand to benefit from a stronger Ethereum price, so his $6,000 target is worth considering alongside the incentives.
Bitmine has been buying heavily into an asset that has suffered a sharp longer-term decline. The company’s Q4 FY25 disclosure showed that ETH had fallen roughly 50% from its ATH of $4,953 reached in August 2025, creating unrealized losses on the treasury. Bitmine still reported $328.16 million in FY2025 net income and fully diluted earnings of $13.39 per share, but the value of its massive ETH position will continue to move with the coin.
If Lee’s forecast is right, those purchases could look very different by year-end. If ETH falls further, the size of the treasury also means the losses could grow quickly.
Does This Move ETH, or Just BMNR? Bitmine is building one of the largest corporate ETH treasuries through a listed company, and BMNR’s market value now sits close to the value of its crypto holdings, giving shareholders high-beta exposure to Ethereum while adding potential staking income through MAVAN.
For ETH holders, the case is less convincing because Bitmine’s purchases remove some coins from the market but do not create the kind of broad demand that can sustain a global asset on its own. The bigger question is whether other buyers follow, particularly through ETFs and institutional channels, while Ethereum continues to attract demand from staking and network activity.
The key questions are whether Bitmine keeps buying ETH at this pace, how much of the buying comes from new shares, and whether the ETH-to-Bitcoin ratio moves from 0.03 toward Lee’s 0.04 target. If those three factors move in Bitmine’s favor, BMNR could benefit significantly from an Ethereum recovery.
For now, the stronger case is that Bitmine’s strategy could move BMNR more than it moves ETH.
Contact [email protected] for any questions or corrections.
Oddity Tech (ODD - Free Report) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.92 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +66.67%. A quarter ago, it was expected that this online retailer of cosmetics and beauty products would post a loss of $0.04 per share when it actually produced a loss of $0.17, delivering a surprise of -325%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Oddity Tech, which belongs to the Zacks Internet - Software industry, posted revenues of $180.52 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 3.27%. This compares to year-ago revenues of $241.14 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Oddity Tech shares have lost about 67.6% since the beginning of the year versus the S&P 500's gain of 12.1%.
What's Next for Oddity Tech?While Oddity Tech has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Oddity Tech was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.10 on $118.35 million in revenues for the coming quarter and $0.06 on $619.4 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Penguin Solutions, Inc. (PENG - Free Report) , has yet to report results for the quarter ended August 2026.
This company is expected to post quarterly earnings of $0.75 per share in its upcoming report, which represents a year-over-year change of +74.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Penguin Solutions, Inc.'s revenues are expected to be $512.5 million, up 51.7% from the year-ago quarter.
It's Not Too Late to Jump on These Under-the-Radar Momentum PlaysODDITY Tech NASDAQ: ODD reported second-quarter 2026 net revenue of $181 million, down 25% from a year earlier, as its IL MAKIAGE brand continued to face higher customer-acquisition costs tied to an advertising-account dislocation with its largest ad partner.
Management said the quarterly revenue result came in at the favorable end of its prior guidance range for a 25% to 30% decline. Adjusted EBITDA was $13 million, above the company’s outlook of $8 million to $10 million, while adjusted diluted earnings per share totaled $0.20.
Get ODDITY Tech alerts:
Oddity Tech's AI-Powered Debut Sparks Optimism For '23 IPO MarketCo-founder and CEO Oran Holtzman said the company remains focused on resolving the issue affecting IL MAKIAGE’s ability to reach intended audiences through its main advertising partner. He said ODDITY and the advertising partner are conducting intensive testing and that the company believes the issue is technical and related to “audience drift” in the partner’s algorithm rather than underlying brand demand.
“Once it’s behind us, we are back to growth,” Holtzman said, adding that IL MAKIAGE has a pipeline of products that the company intends to support once customer-acquisition costs normalize.
IL MAKIAGE Pressure Weighs on Sales and Margins Global CFO Lindsay Drucker Mann said IL MAKIAGE’s advertising disruption affected first-order revenue most heavily, while also reducing repeat purchases tied to advertising activity. Companywide net revenue from first orders declined about 40% year over year in the second quarter, driven by IL MAKIAGE, while repeat-order revenue fell about 20%.
Average order value declined approximately 8% from the prior-year period. Drucker Mann attributed the decline largely to lower IL MAKIAGE average order values, reflecting fewer first orders, which typically carry higher order values than repeat purchases, as well as a product-mix shift away from IL MAKIAGE skin products.
Gross margin fell to 68.7% from 72.3% a year earlier, a decline of approximately 360 basis points. The company cited lower average order values as a factor. Drucker Mann said ODDITY does not view the margin pressure as structural, noting that its longer-term gross-margin expectation remains in the high-60% range and that improved acquisition conditions should allow the company to resume optimizing for average order value.
Holtzman said the company is also expanding its efforts across distribution and advertising channels to make the business more resilient, though he did not announce specific initiatives. He said maintaining a substantial direct-to-consumer business remains important because of the customer data it provides.
SpoiledChild and METHODIQ Provide Growth Areas While IL MAKIAGE faced pressure, management highlighted continued momentum at SpoiledChild and early progress from the recently launched METHODIQ brand.
SpoiledChild is expected to grow at least 35% in 2026 and approach $350 million in net revenue, according to Holtzman. He said the wellness brand continued to generate strong customer cohort metrics, including average order value and repeat purchasing. Twelve-month net-revenue repeat rates at SpoiledChild are above 100%, management said.
The company said SpoiledChild has been affected by the same advertising-algorithm issue, but to a lesser degree than IL MAKIAGE. ODDITY increased acquisition spending behind SpoiledChild during the quarter, citing attractive expected 12-month contribution margins. Holtzman said the company plans to continue international expansion for the brand and has more than eight products and categories planned for next year.
METHODIQ, which launched several months ago, is expected to generate more first-year revenue than SpoiledChild did in its first year, according to management. The medical-grade brand launched with 30 products spanning non-prescription offerings, prescription products and personalized treatment protocols.
Holtzman pointed to hyperpigmentation as an early area of traction for METHODIQ. The brand uses computer vision to assess dark spots and uneven skin tone, with the resulting data provided to a healthcare provider that can issue a personalized treatment plan. He said one of METHODIQ’s products, Melanex 509, uses ODDITY LABS’ patented molecule combination called ODDL1007.
The company also plans to expand METHODIQ into additional categories in 2027. Holtzman said a category of particular interest is longevity and metabolic health, where the company intends to offer legally available prescription injectable and peptide therapies.
Outlook Calls for Sequential Improvement For the third quarter, ODDITY expects net revenue to decline approximately 5% year over year, representing a meaningful improvement from the first half of 2026. The company expects adjusted EBITDA of $18 million to $20 million.
For the full year, ODDITY forecast a net-revenue decline of approximately 19% and adjusted EBITDA between $30 million and $32 million. Drucker Mann said the company expects stronger repeat revenue in the second half but is maintaining a conservative fourth-quarter outlook because it has not yet determined how much advertising spending will be directed toward testing versus revenue generation.
The company ended the quarter with $561 million in cash equivalents and investments, while its $350 million in credit facilities remained undrawn. During the quarter, ODDITY repurchased 5.6 million shares for $80 million, bringing year-to-date repurchases to 11.7 million shares for $163 million. The company said those repurchases reduced ordinary shares outstanding by approximately 20%, with about $87 million remaining under its $200 million repurchase authorization.
ODDITY also repurchased $50 million face value of its zero-coupon June 2030 exchangeable notes for $35 million during June. Management said it plans to remain opportunistic in managing its capital structure.
About ODDITY Tech (NASDAQ:ODD)Oddity Tech Ltd. operates as a consumer tech company that builds digital-first brands for the beauty and wellness industries in the United States and internationally. It serves consumers worldwide through its AI-driven online platform, which uses data science, machine learning, and computer vision capabilities to identify consumer needs, and develop solutions in the form of beauty and wellness products. The company sells beauty, hair, and skin products under the IL MAKIAGE and SpoiledChild brands.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in ODDITY Tech Right Now?Before you consider ODDITY Tech, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ODDITY Tech wasn't on the list.
While ODDITY Tech currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Two AI infrastructure companies just reported earnings with the same tailwind behind them and completely opposite strategies in front of them, and only one of those playbooks survives a construction delay or a GPU slip.
Nebius Group (NASDAQ: NBIS | NBIS Price Prediction) and IREN (NASDAQ: IREN) both just delivered results that reveal how differently two AI infrastructure builders can attack the same shortage. Nebius reported Q2 FY26 on August 12, showcasing a from-scratch cloud platform. IREN followed on August 27 with a Bitcoin miner turning its power footprint into GPU factories. Same tailwind, wildly different playbooks.
Software Stack Lifts Nebius. Power Portfolio Lifts IREN. Nebius booked $582.3 million in Q2 revenue, up 454% year over year, with the AI Cloud unit alone hitting $574.9 million and a 50% adjusted EBITDA margin. CEO Arkady Volozh told investors “We could sell today our entire 2027 capacity on these terms if we wanted to”, a rare position for a cloud operator. Aether, Token Factory, and the Tavily acquisition, whose developer community grew to more than 2.5 million, extend Nebius beyond bare metal.
IREN posted $137.2 million in revenue, down 26.75%, as mining rigs came offline. A $450.4 million non-cash impairment drove a $684.0 million net loss. The pivot story is inside the mix: AI Cloud revenue reached $70.5 million and more than doubled sequentially. CEO Daniel Roberts framed the edge plainly: “Signing deals is not the bottleneck in this market. Bringing GPUs online is.”
Scale Versus Efficiency, Side by Side Lens Nebius IREN Core Bet Full-stack AI cloud plus software Owned power, land, and data centers Contracted Backlog $37.5B RPO $4B contracted ARR target by Dec 2026 Power Pipeline 5GW year-end target 5GW+ pipeline Anchor Deal $27B Meta Platforms (NASDAQ:META) agreement $3.4B NVIDIA (NASDAQ:NVDA) contract Nebius is optimizing for pricing power. Its first capacity auction cleared at a price 15% above its prior high for Blackwell. IREN is optimizing for cost per megawatt. Recent three-year deals price above $20 million per MW, with active talks near $25 million, and Roberts noted “Every megawatt we build is scarce.”
What Decides the Next Four Quarters I will be watching whether Nebius can convert its $40 billion-plus in customer commitments into asset-backed financing without leaning on equity again after selling 12.7 million shares at $224. You should watch whether IREN delivers Horizons 2 through 4 to Microsoft (NASDAQ:MSFT) on schedule, since a significant portion of December-quarter capacity comes online late. Both stories hinge on execution.
Why I Lean Nebius for Now, But Keep IREN Close Personally, I lean toward Nebius today. A 50% AI Cloud EBITDA margin, a software layer that lifts monetization, and $8 billion in cash make the scale-out feel financeable. The stock is not cheap after a 156.88% six-month run, so valuation discipline matters. IREN suits a turnaround investor comfortable with impairments and construction risk in exchange for the rarest input in the industry: energized land. If Horizons 2 through 4 ship on time and pricing holds near $25 million per MW, IREN’s 20.83% six-month gain looks like the setup with room to run. Both names carry timing risk if GPU supply slips.
Contact [email protected] for any questions or corrections.
According to GMGN market data, the Solana-based meme coin CATE has rebounded to a market cap exceeding $50 million, currently trading at $51.54 million, with a 24-hour increase of over 99% and a 24-hour trading volume of $12.8 million. Earlier on July 26, Atsuko Sato, owner of Kabosu—the Shiba Inu that inspired the Doge meme—posted a video of a kitten. The community quickly launched the token on Pump.fun, positioning it as "the successor to Doge / the cat version of Doge" to carry on the meme culture of "dogs came first, now it's the cats' turn". Subsequently, Atsuko Sato clarified in a post that the CATE tokens circulating in the recent market have no connection with her at all. She stated that she only shared a moment on Instagram before, but this content was later used without authorization by others, who took advantage of it to issue fake tokens and create the illusion of a link with her. She expressed regret over this, noting that some accounts involved in spreading related information even include users with considerable influence on the X platform. BlockBeats reminds users that most meme coins have no practical use cases and feature highly volatile prices, so investment requires caution.
Approximately $1.2 billion investment expected to create about 490 high-skill, high-wage manufacturing jobs in South Carolina’s UpstateBlacksburg facility will serve as a cornerstone of USA Rare Earth’s domestic magnet manufacturing footprint and advance the Company’s integrated mine-to-magnet value chainInvestment strengthens U.S. capacity to produce critical rare earth metals and magnets for defense, aerospace, semiconductors, energy and other advanced industries BLACKSBURG, S.C., Sept. 09, 2026 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (“USA Rare Earth,” “USAR” or the “Company”), a rare earth, critical minerals and advanced materials company, today broke ground on its new rare earth metal and magnet manufacturing facility in Blacksburg, South Carolina, marking a major step in the Company’s effort to build a secure, integrated rare earth supply chain for the United States and its allies.
Located on a 124-acre site in Bailey Industrial Park in Cherokee County, the approximately 800,000-square-foot facility represents an approximately $1.2 billion investment and is expected to create roughly 490 high-skill, high-wage manufacturing jobs in South Carolina’s Upstate. Once online, the facility is targeting production capacity of 6,400 metric tons per annum (tpa) of sintered neodymium-iron-boron (NdFeB) permanent magnets and 5,000 tpa of strip-cast metal and alloy, with commissioning targeted to begin in 2028.
“Breaking ground in Blacksburg is an important moment because it moves our vision from plans on paper to infrastructure taking shape,” said Barbara Humpton, Chief Executive Officer of USA Rare Earth. “We’re building the capabilities America needs to make critical rare earth materials and magnets at home, while making a long-term investment in the people and communities that will help us do it. We’re proud that the next chapter of USA Rare Earth’s growth is being built here in South Carolina.”
Investing in South Carolina and the Upstate
USA Rare Earth selected Blacksburg following a comprehensive evaluation of nearly 275 potential sites across the country. South Carolina stood out for its skilled advanced manufacturing workforce, reliable power, transportation infrastructure, proximity to customers and suppliers, and strong support from state and local partners. Located along the Interstate 85 corridor, the operation will add to an advanced manufacturing ecosystem that has made the Upstate an important center of American industrial production.
As part of its broader commitment to Cherokee County and the region’s growing manufacturing economy, USA Rare Earth today also announced a $250,000 contribution to Spartanburg Community College to support its new SPARK Center in Cherokee County. The new center will connect education, workforce development and economic development, providing resources to support businesses locating, launching and growing in the county while helping strengthen the local talent pipeline and broader business ecosystem.
“This Blacksburg community has the infrastructure, talent and manufacturing heritage to support what we’re building, but just as important has been the commitment we’ve seen from people across Blacksburg, Cherokee County and South Carolina,” said David Bushi, Senior Vice President of Manufacturing at USA Rare Earth. “We intend to build something here that creates opportunity locally and strengthens American manufacturing for decades to come.”
“South Carolina’s greatest strength has always been our people and their ability to build things the world depends on,” said South Carolina Governor Henry McMaster. “USA Rare Earth’s decision to put down roots in Blacksburg is another tremendous vote of confidence in our workforce and in the manufacturing future of our state. Today, we celebrate the start of a project that will create new opportunities for families across Cherokee County and the Upstate while helping America rebuild a critical industry here at home.”
Building a Secure, Integrated Rare Earth Supply Chain
The groundbreaking also marks an important milestone in USA Rare Earth’s broader strategy to build and grow a secure, globally integrated rare earth value chain that reduces reliance on concentrated sources of supply. Rare earth metals and permanent magnets are essential inputs across defense, aerospace, semiconductor manufacturing, physical AI, mobility, energy, healthcare and other advanced industries. Yet the United States remains heavily dependent on foreign sources for many of these critical materials and manufacturing capabilities, with China dominating significant portions of the global rare earth supply chain.
USA Rare Earth is working to change that by building capabilities across the full value chain — from mining and processing to separation, metal- and alloy-making and permanent magnet manufacturing.
The Blacksburg facility will complement USA Rare Earth’s existing magnet manufacturing operation in Stillwater, Oklahoma, where the Company commissioned its first commercial production line earlier this year. Together, Blacksburg and the planned expansion at Stillwater are expected to provide USA Rare Earth with 10,000 tpa of domestic NdFeB magnet manufacturing capacity. The Company is also investing in and expanding capabilities across its broader global platform, supporting local production and economic development while connecting critical rare earth resources with advanced manufacturing markets globally.
“A secure rare earth supply chain isn’t built with a single mine or a single factory. It requires rebuilding every link,” said Gregory Bowman, Chief Global Policy Officer of USA Rare Earth. “Blacksburg adds critical manufacturing capacity to that broader platform and brings the United States closer to producing more of the materials and magnets our industries depend on outside of Chinese control. What starts with a groundbreaking here in South Carolina ultimately strengthens America’s industrial and national security.”
Partnership Turning Vision Into Reality
USA Rare Earth is working with a team of construction, development, engineering and technology partners to bring the Blacksburg facility online.
Clark Construction Group and Frampton Construction are serving as design-builder through the Clark/Frampton joint venture, with Trammell Crow Company serving as developer. McMillan Pazdan Smith is serving as project architect in collaboration with Bennett & Pless, Thomas & Hutton and Salas O’Brien. Chang Robotics is bringing expertise in advanced manufacturing, automation and robotics.
“Large-scale manufacturing investments succeed when ambition is matched by disciplined execution,” said Spencer Middleton, vice president with Clark Construction. “Our focus is on translating the significance of this project into a construction effort that is equally rigorous, bringing the right people, resources, and planning together to deliver for USA Rare Earth and South Carolina.”
“Projects of this scale demand a different level of alignment from the start,” said Dave Florence, chief strategy officer at Frampton Construction. “The decisions made early, the trust established across the team, and the ability to solve problems together all shape what happens in the field. We’re proud to help deliver an investment that will expand advanced manufacturing in South Carolina and strengthen domestic production for years to come.”
About USA Rare Earth
USA Rare Earth, Inc. (Nasdaq: USAR) is building a fully integrated rare earth and permanent magnet value chain across the United States, Brazil and the United Kingdom. Through its ownership of Less Common Metals (LCM), one of the world’s leading producers of rare earth metals and alloys, its development of magnet manufacturing capacity in Stillwater, Oklahoma, the Pela Ema mine in Brazil and the Round Top deposit in Texas, USA Rare Earth operates across the entire value chain from mining to metal-making, alloy production and neodymium magnet manufacturing. USA Rare Earth is establishing a secure, Western-aligned supply of materials essential to the aerospace and defense, semiconductor, energy, data center, physical AI, mobility, healthcare and industrial sectors. For more information, visit www.usare.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include those relating to the expected capital investment, job creation, production capacity and commissioning timeline of the planned rare earth metal and magnet manufacturing facility in Blacksburg, South Carolina, anticipated development of Spartanburg Community College’s new SPARK Center, the potential impact of the Blacksburg facility on domestic magnet manufacturing and the rare earth value chain and other statements regarding the Company’s expectations for future development, operations, strategies, transactions and financial performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. Words such as “aim,” “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “growth,” “intend,” “may,” “might,” “plan,” “potential,” “project,” “propose,” “should,” “target,” “vision,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
Forward-looking statements are subject to risks and uncertainties and potentially inaccurate assumptions that could cause actual results to differ materially from our expectations, including without limitation: risks associated with permitting, construction, workforce availability, the ability of our planned Blacksburg facility to commence commercial operations on the timing and with the production capacity anticipated or at all; risks that we may experience delays, unforeseen expenses, increased capital costs, and other complications while developing our projects; our ability to raise necessary capital on acceptable terms or at all; the availability of rare earth oxide, metal feedstock and other materials, utilities (including power and water) and equipment in quantities and prices that allow us to develop and commercially operate our Stillwater facility and other facilities; our ability to meet individual customer specifications and produce a consistently high quality product; potential supply chain, logistics or product delivery disruptions; any delays in obtaining or renewing permits and licenses; fluctuations in demand for and prices of neo magnets, rare earth elements and our other products, including without limitation as a result of dumping, predatory pricing and other tactics by our competitors or state actors or the overall competitive environment; risks that we may not realize the anticipated benefits of USA Rare Earth’s combination with Serra Verde or our proposed and prior acquisitions, including expected synergies, financial performance, estimated earnings before interest, taxes, depreciation and amortization and, in the case of Serra Verde, integration of operations, on the anticipated timeline or at all; potential delays in the optimization and commissioning program and the Phase II expansion at the Pela Ema facility; political, economic, regulatory, tax, currency and other risks associated with Serra Verde’s operations in Brazil and Switzerland; physical climate risks related to the Pela Ema mine; the assumption of substantial indebtedness under Serra Verde’s Retained Finance Agreement, which contains restrictive covenants and other requirements that could adversely affect the combined company’s financial flexibility and operations; risks that the Offtake Agreement is terminated or ceases to be in full force and effect or that the counterparty to the Offtake Agreement is insufficiently capitalized, including as a result of a failure to finalize definitive debt financing arrangements within the timeframes contemplated by the Offtake Agreement; risks that the proposed transaction with Carester SAS may not be consummated on its anticipated timeline or at all; the ability of our Stillwater magnet manufacturing facility to generate revenue; our limited operating history; our ability to commercially extract minerals from the Round Top deposit on our anticipated timeline or at all; differences between planned and actual recovery and yield rates; potential dilution to existing stockholders and adverse effect on our stock price if we issue additional common stock or equity-linked securities; the volatility of our stock price; any changes in royalty rates or the imposition of new royalties; risks associated with community relations; our ability to achieve positive cash flow or profitability or the ability to access cash flow within our corporate structure due to restrictions contained in our financing agreements; our ability to convert current commercial discussions and/or memorandums of understanding with customers for the sale of our neo magnets and other products into definitive orders; our dependence, in part, on the growth of existing and emerging uses for neo magnets; the risk that additional manufacturing, refining and mining competitors could result in a reduction in revenue; geopolitical developments or disruptions, such as changes in the political environment, export/import or environmental policy of the People’s Republic of China, the United States or other countries in which we operate or sell products or otherwise; our designation on an export control list by China which has had and is expected to continue to have an adverse impact on our ability to source key raw materials and supplies from China; war, terrorism, natural disasters or public health emergencies; our ability to retain or recruit key personnel; environmental, health and safety regulations; the receipt of funding from the U.S. Department of Commerce is subject to the achievement of milestones which may not be achieved on the expected timeline or at all; and our ability to comply with requirements for federal, state and local government incentives and financing.
Additional risks and detailed information regarding factors that may cause actual results to differ materially has been and will be included in our filings with the SEC, including our most recently filed Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and subsequent filings. Any forward-looking statements speak only as of the date of this press release (or such other date as is specified in such statements), and we undertake no obligation to update any forward-looking statements as a result of new information or future events or developments.
Investor Relations Contact
J.B. Lowe, CFA
USA Rare Earth, Inc. [email protected]
Media Relations Contact
Collected Strategies
Dan Moore / Scott Bisang [email protected]
Certification validates that the company's automotive cybersecurity engineering and management processes meet internationally recognized requirements
, /PRNewswire/ -- Silicon Motion Technology Corporation (NasdaqGS: SIMO), a global leader in designing and marketing NAND flash controllers for solid-state storage devices, today announced that it has earned ISO/SAE 21434:2021 Automotive Cybersecurity Process Certification from SGS-TÜV Saar. The certification independently validates that Silicon Motion's automotive cybersecurity development and management processes meet the requirements of ISO/SAE 21434, the internationally recognized standard for cybersecurity engineering in road vehicles. This achievement demonstrates the company's ability to systematically identify, assess and manage cybersecurity risks throughout the automotive product lifecycle, reinforcing its commitment to delivering secure and reliable automotive storage solutions.
ISO/SAE 21434 Automotive Cybersecurity Process Certification ISO/SAE 21434 was developed to address the growing cybersecurity risks created by increasingly connected and software-defined vehicles. It provides a structured framework for identifying, assessing and managing cybersecurity risks throughout the lifecycle of automotive electrical and electronic systems. The standard also provides a recognized engineering framework that supports compliance with UNECE UN Regulation No. 155 (UN R155), including its Cyber Security Management System (CSMS) requirements for vehicle type approval in the European Union. By establishing common processes, responsibilities and documentation requirements, ISO/SAE 21434 helps automakers and suppliers integrate cybersecurity into product development, meet evolving regulatory expectations and respond effectively to emerging threats.
"As a leading provider of automotive storage solutions with more than a decade of industry experience, Silicon Motion recognizes that cybersecurity is fundamental to the development of next-generation connected and software-defined vehicles," said Nelson Duann, Senior Vice President of Edge and Automotive Storage Business at Silicon Motion. "Earning this certification reflects our commitment to embedding cybersecurity throughout the product lifecycle and delivering secure, reliable and automotive-grade storage solutions that help customers meet evolving cybersecurity requirements."
"ISO/SAE 21434 establishes a rigorous, internationally recognized benchmark for managing cybersecurity risks throughout the automotive product lifecycle," said Robert Chang, C&P Division VP of SGS Taiwan. "By earning this process certification, Silicon Motion has demonstrated that its automotive cybersecurity development and management processes meet this high standard, underscoring the company's capabilities and commitment to secure and reliable product development for the global automotive industry."
Silicon Motion will continue to advance its automotive cybersecurity capabilities and deliver a comprehensive portfolio of secure and reliable storage solutions for connected, software-defined and AI-powered vehicles. Through ongoing innovation and close collaboration with partners across the global automotive ecosystem, the company remains committed to advancing trusted storage technologies for the future of intelligent mobility. For more information, visit Silicon Motion Automotive Solutions.
About Silicon Motion
Silicon Motion Technology Corporation (NasdaqGS: SIMO) is the global leader in supplying NAND flash controllers for solid-state storage devices. The company ships more SSD controllers than any other supplier worldwide for servers, PCs, and other edge devices, and is also the leading merchant provider of eMMC and UFS embedded storage controllers used in smartphones, IoT products, and automotive applications.
Silicon Motion also delivers customized, high-performance controller solutions for enterprise SSDs, enterprise boot drives, edge SSDs, embedded eMMC and UFS devices, and Ferri solutions for automotive and Physical AI applications. Its controllers and storage solutions combine high performance, power efficiency and proven reliability to support AI infrastructure, Edge AI and Physical AI applications.
Analyst’s Disclosure: I/we have a beneficial long position in the shares of SNDK either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Centrus Energy Corp. (NYSE:LEU) is trending after the company announced a multi-year contract with Radiant to supply high-assay, low-enriched uranium for the Kaleidos microreactor fleet.
Centrus stock is showing downward pressure. Where is LEU stock headed? Centrus, Radiant Sign HALEU Supply DealUnder the agreement, Centrus will begin delivering HALEU before the end of the decade, adding another domestic fuel source to support commercial scale-up of Radiant’s Kaleidos microreactors. The deal includes prepayments from Radiant to Centrus to support its domestic commercial enrichment capacity program. Because Centrus’ technology is U.S.-origin and relies on a U.S. manufacturing supply chain, the enrichment provided to Radiant will be “unobligated,” meaning it can be used for national security applications — a capability Centrus says is unique among deployment-ready U.S.-origin enrichment technologies today, through its AC100 centrifuge design.
“The contract with Radiant marks another important step in building the domestic fuel supply chain needed to support the next generation of nuclear energy,” said Amir Vexler, President and CEO of Centrus. “By expanding our work to include innovative microreactor developers like Radiant, we are strengthening the U.S.-based fuel supply network.”
“You can’t deploy nuclear reactors without fuel, so we have approached our fuel supply the same way we have approached the reactor: build it in parallel, and don’t depend on any single path,” said Dr. Rita Baranwal, Chief Nuclear Officer of Radiant. “This agreement gives Kaleidos a continued source of HALEU for commercial and national security applications and removes one of the biggest constraints facing advanced nuclear deployment.”
Read Next
Centrus Shares Trade FlatLEU Price Action: At the time of publication, Centrus shares are trading 0.69% lower at $184.25, according to data from Benzinga Pro.
This illustration was generated using artificial intelligence via Midjourney.
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
UroGen Pharma Ltd. has transitioned into a commercial-stage biopharma, driven by strong adoption of Zusduri for recurrent non-muscle invasive bladder cancer. Zusduri achieved an 80% complete response rate in the ENVISION trial, with a 64.5% chance of remaining disease-free at 3 years among responders. URGN-103, a next-generation mitomycin-based product, is positioned to replace Zusduri, offering manufacturing and convenience advantages; NDA submission is complete and approval is likely.
TD Securities’ Ryan McKay and Bart Melek say Gold and broader precious metals have held firm despite higher near-term Fed hike probabilities. They stress that upcoming US inflation data will be pivotal for Fed pricing and discretionary flows, while structural supports such as Dollar-debasement themes, central bank buying and ETF demand suggest any hawkish shock may delay rather than derail the next leg higher.
Fed pricing hinges on inflation print"Precious metals wait on inflation data."
"Precious metals have been able to maintain strength, even as the market grapples with the near-term increase in Fed hike probabilities."
"A stronger jobs report initially weighed on gold, but less hawkish Fedspeak and currency interventions then cooled the narrative, highlighting the market has an elevated sensitivity to incoming data and headlines."
"Inflation data is the next big catalyst, and an upside surprise would embolden Fed pricing and weigh on the yellow metal, while less worrisome inflation could ultimately be the first catalyst to see the next wave of discretionary positioning start to enter the market."
"With the precious metal landscape still broadly supported by the renewed dollar-debasement theme, elevated central bank buying and renewed ETF accumulation, a hawkish Fed may only postpone the timing of the next leg higher rather than catalyze material downside."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor. Know more.)
EURGBP jumps 0.3% on Wednesday as Euro gets inflated by weaker dollar and expectations that the ECB will join the trend of policy tightening by the major central banks, while the Bank of England is likely to keep more cautious approach and probably keep rates on hold that keeps sterling in defense.
Fresh strength retraces over 61.8% of 0.8607/0.8564 pullback that partially offsets negative signal from bull-trap pattern on daily chart (failure to sustain gains above 0.8600 – Fibo 61.8% of 0.8689/0.8454 / 100DMA).
Bounce and likely repeated close above daily Ichimoku cloud (0.8572) supports the notion, but sustained break above 0.8600 pivot is still required to bring bulls fully in play and generate initial signal of bullish continuation of rally from 0.8454 (July 15 low).
Predominantly bullish daily technical studies, particularly while the price holds above daily cloud top, supports positive near-term outlook.
The information contained in this document was obtained from sources believed to be reliable, but its accuracy or completeness cannot be guaranteed. Any opinions expressed herein are in good faith, but are subject to change without notice. No liability accepted whatsoever for any direct or consequential loss arising from the use of this document.
Quiq Capital LLC is a boutique asset manager providing secured loans to Small and Medium Sized Enterprises & Real Estate Strategies
, /PRNewswire/ -- Quiq Capital LLC and Quiq Income Fund II, L.P. ("Quiq" or the "Fund") are pleased to announce it has entered into an amendment and upsize to its revolving credit facility (the "Facility") with Dime Commercial Bancshares, Inc. (NYSE: DCOM), the parent company of Dime Commercial Bank (the "Bank" or "Dime"). The amendment affords Quiq the ability to, among other things, increase the borrowing capacity to $30.0 million, reduce the interest rate and provide additional financial flexibility and liquidity to support business growth.
"We are very pleased to announce this amendment and upsize to our Facility with Dime," said Ashish Parikh, Principal at Quiq Capital. "The increased borrowing capacity is a testament to our growing capital base and strong fund performance since launching our Fund in 2024. The amended facility not only reduces our borrowing costs, but it also enhances our flexibility to fund attractive opportunities with compelling, risk-adjusted returns. Additionally, we believe our strong performance and our growing partnership with Dime provide us optionality to pursue strategic financings while remaining disciplined and prudent with our capital."
"Since entering our lending relationship with Quiq in 2025, we have been able to meaningfully grow our relationship in a short period of time, and our partnership is emblematic of the relationships that we strive to foster with new and existing clients. We look forward to working with the talented team at Quiq and continuing to provide bespoke capital solutions for this fast-growing firm." said Shawn Gines, Executive Vice President and Head of Corporate & Specialty Finance at Dime Commercial Bank.
ABOUT QUIQ
Quiq Capital LLC is a boutique asset manager that provides secured loans to Small and Medium Sized Enterprises ("SMEs") and Real Estate Strategies. The Fund is a private credit lender that creates high-value, risk-adjusted investments by empowering the growth of lower middle market businesses. Through private capital and structured lending, the Fund provides critical funding for asset-backed and high-growth profitable businesses with a proven track record of outperformance and strong governance.
ABOUT DIME COMMERCIAL BANCSHARES, INC.
Dime Commercial Bancshares, Inc. is the holding company for Dime Commercial Bank, a New York State-chartered trust company with approximately $15 billion in assets and the number one deposit market share on Greater Long Island (1).
(1)Aggregate deposit market share for Kings, Queens, Nassau & Suffolk counties for community banks with less than $20 billion in assets.
Forward-Looking Statements
This press release may contain forward-looking statements, including, without limitation, statements regarding the plans and objectives of management for future operations. These statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of Quiq Capital LLC and Quiq Income Fund II, L.P. to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements.
Key Takeaways Seagate's HAMR-based products reached about 40% of its nearline exabyte shipment run rate.Mozaic 4, supporting capacities up to 44TB, is ramping with two major cloud service providers.HAMR investments aim to drive mid-20% nearline exabyte growth while keeping unit output relatively stable. Seagate Technology Holdings plc’s (STX - Free Report) technology roadmap is key to its ability to capitalize on rising storage demand. STX’s expertise in materials science, precision manufacturing, photonics and wafer production has driven HAMR and the Mozaic platform, while vertical integration in laser manufacturing further strengthens its technology edge.
Seagate’s areal-density roadmap enables it to expand exabyte output without materially increasing hard-drive unit production. This improves capital efficiency and lowers customers’ cost and power consumption per terabyte. HAMR-based products accounted for approximately 40% of Seagate’s nearline exabyte shipment run rate at the end of fiscal 2026. Mozaic 3 products are qualified and operating across all major cloud customers, while the second-generation Mozaic 4 platform, capable of supporting capacities up to 44 terabytes, is ramping with the two largest global cloud service providers.
Seagate expects 50% of HAMR exabytes to come from Mozaic 4 by the end of calendar 2026. Mozaic 5 qualification shipments remain on track for late calendar 2027. Higher-capacity products should also benefit profitability. The transition from three-terabyte-per-disk to four-terabyte-per-disk products provides additional cost efficiencies, while tight industry supply is supporting favorable pricing on incremental exabyte availability.
Seagate delivered strong double-digit year-over-year growth in both revenue and exabyte shipments in the enterprise OEM market during the June quarter. The company is expanding HAMR across its portfolio, initially targeting cloud customers and gradually broader enterprise adoption. Investments in HAMR manufacturing tools should support higher-capacity drives while keeping unit output relatively stable, enabling mid-20% nearline exabyte growth over the next few years.
How STX Stacks Up Against Market Peers in the Storage CircleWestern Digital Corporation (WDC - Free Report) is developing and deploying higher-capacity ePMR, UltraSMR and HAMR drives, along with high-bandwidth drive technology for data-intensive workloads. Its product roadmap includes ePMR drives with capacities up to 40 TB, 44-TB HAMR products planned for the first half of calendar 2027 and 50-TB products planned for the second half of calendar 2027. WDC expects the 40-TB ePMR transition, wider UltraSMR adoption and subsequent HAMR introduction to expand the number of exabytes it can deliver without adding unit capacity. Management also cited increased enterprise OEM interest in hybrid storage systems and is working with those customers on UltraSMR, next-generation ePMR and HAMR adoption.
Micron Technology (MU - Free Report) is benefiting from AI-driven demand for memory and storage, tighter DRAM and NAND supply and a richer mix of HBM, data center SSD and high-capacity products. Micron’s technology roadmap is strengthening its exposure to high-value memory solutions used in AI, machine learning and data analytics. Its 1-gamma DRAM node and G9 NAND node are ramping up well and are on track to become the highest-volume nodes in Micron’s history. Development of next-generation DRAM and NAND nodes is set to begin volume production in the second half of calendar 2027. These advances deepen Micron’s role in data center, client, mobile and automotive platforms.
STX Price Performance, Valuation and EstimatesIn the past year, STX shares have skyrocketed 368.5%, outperforming the Computer Integrated Systems industry’s growth of 201.3%.
Image Source: Zacks Investment Research
Going by the price/earnings ratio, the company’s shares currently trade at 22.61 forward earnings compared with 12.11 for the industry.
Image Source: Zacks Investment Research
STX is currently witnessing an uptrend in estimate revisions. Earnings estimates for fiscal 2027 have been revised up 28.7% to $36.09 over the past 60 days, while estimates for fiscal 2028 have risen 17.8% to $58.28.
Image Source: Zacks Investment Research
STX currently boasts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
SailPoint SAIL is experiencing a significant drop in pre-market trading following a slight revenue miss for fiscal Q2 and guidance for Q3 that did not exceed expectations. Investors seem to be concentrating on revenue timing, flat adjusted margins, and declining free cash flow, overlooking stronger recurring revenue indicators.
Fiscal Q2 Highlights: Adjusted EPS of $0.09 exceeded the FactSet consensus by $0.01. Revenue rose 17% year-over-year to $309 million, slightly below the expected $310.25 million. SaaS revenue surged 34% to $194 million, but revenue recognition timing created a $5 million headwind. Annual Recurring Revenue (ARR): Total ARR increased 25% to $1.231 billion. SaaS ARR grew 36% to $847 million, contributing 97% of net new ARR, surpassing the anticipated 90-95%. Remaining Performance Obligations (RPO) rose 30% to $1.9 billion, with current RPO up 27% to $931 million. Q3 Guidance: EPS guidance is set at $0.07-$0.08, with revenue expectations of $326-$330 million, both in line with forecasts. FY27 revenue and EPS guidance remain at $1.265-$1.275 billion and $0.30-$0.34, respectively. FY27 ARR guidance was raised to $1.375-$1.385 billion, indicating 22-23% growth. AI Adoption: AI-driven ARR surpassed $70 million, accounting for over 30% of net new ARR. More than two-thirds of migrations included AI solutions, with existing customers increasing their annual spending by over 60% when adopting AI products. The AI pipeline has more than doubled since the June Investor Day. Customer Metrics: SaaS customers increased by 16%, with ARR per SaaS customer rising 17% to over $400,000. Customers spending over $1 million grew by 27% to 235, while net retention remained steady at 113%. Adjusted operating margin held nearly flat at 20.3%, adjusted net income increased by 22% to $48.8 million, while free cash flow fell to $37.4 million from $46.0 million.The recent report highlights a stark contrast between reported revenue and underlying contract momentum. Although the higher SaaS mix temporarily impacted revenue, it enhanced the recurring quality of the business. The raised ARR guidance and strong RPO suggest that demand is stronger than the headline figures indicate. SailPoint must now focus on scaling AI-driven ARR from over $70 million to at least $800 million by FY29, while managing investments related to Entro, stock-based compensation, and the pressures of transitioning to SaaS. Future performance will hinge on ARR growth, AI expansion, stable subscription margins, and converting backlog into revenue and free cash flow.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Disclosures I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.
SailPoint, Inc. (SAIL - Free Report) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +12.50%. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced earnings of $0.05, delivering a surprise of +25%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
SailPoint, Inc. , which belongs to the Zacks Internet - Software industry, posted revenues of $308.81 million for the quarter ended July 2026, missing the Zacks Consensus Estimate by 0.51%. This compares to year-ago revenues of $264.36 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
SailPoint, Inc. shares have lost about 12.1% since the beginning of the year versus the S&P 500's gain of 12.1%.
What's Next for SailPoint, Inc. ?While SailPoint, Inc. has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for SailPoint, Inc. was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.08 on $327.91 million in revenues for the coming quarter and $0.32 on $1.27 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, BlackBerry (BB - Free Report) , is yet to report results for the quarter ended August 2026. The results are expected to be released on September 24.
This cybersecurity software and services company is expected to post quarterly earnings of $0.04 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
BlackBerry's revenues are expected to be $143 million, up 10.3% from the year-ago quarter.
SailPoint, Inc. (SAIL - Free Report) reported $308.81 million in revenue for the quarter ended July 2026, representing a year-over-year increase of 16.8%. EPS of $0.09 for the same period compares to $0.07 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $310.4 million, representing a surprise of -0.51%. The company delivered an EPS surprise of +12.5%, with the consensus EPS estimate being $0.08.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how SailPoint, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Annual Recurring Revenue: $1.23 billion compared to the $1.22 billion average estimate based on three analysts.SaaS Annual Recurring Revenue: $847 million versus $834.94 million estimated by three analysts on average.Customers: 3,310 versus the two-analyst average estimate of 3,288.Revenue- Services and other: $13.61 million compared to the $14.86 million average estimate based on four analysts. The reported number represents a change of -14.9% year over year.Revenue- Subscription: $295.21 million compared to the $295.52 million average estimate based on four analysts. The reported number represents a change of +19.1% year over year.Revenue- Subscription- Other subscription services: $9.67 million versus $8.89 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +46.8% change.Revenue- Subscription- Term subscriptions: $56.2 million versus the three-analyst average estimate of $56.52 million. The reported number represents a year-over-year change of -3.3%.Revenue- Subscription- SaaS: $193.87 million compared to the $193.85 million average estimate based on three analysts. The reported number represents a change of +33.9% year over year.Revenue- Subscription- Maintenance and support: $35.47 million versus $36.43 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -7.8% change.Gross profit- Subscription: $211.1 million versus the two-analyst average estimate of $216.45 million.Gross profit- Services and other: $-5.72 million versus $-3.19 million estimated by two analysts on average.View all Key Company Metrics for SailPoint, Inc. here>>>
Shares of SailPoint, Inc. have returned -6.7% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Perma-Pipe International Holdings, Inc. (Nasdaq: PPIH) ("Perma-Pipe" or the "Company"), a global leader in engineered pipe services specializing in anti-corrosi
Detailed Phase 3 CANOPY-HCH-3 data in children living with hypochondroplasia also featured in a late-breaking oral presentation at the European Society for Paediatric Endocrinology (ESPE) 2026 Annual Meeting
VOXZOGO demonstrated statistically significant improvements across multiple measures of growth, including annualized growth velocity, standing height, height Z-score and arm span
BioMarin recently submitted a supplemental New Drug Application (sNDA) to the FDA to support expanding treatment with VOXZOGO to include children with hypochondroplasia
, /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced new data from the Phase 3 CANOPY-HCH-3 study evaluating VOXZOGO® (vosoritide) in children with hypochondroplasia were published in New England Journal of Medicine (NEJM) Evidence and presented at the European Society for Paediatric Endocrinology (ESPE) 2026 Annual Meeting. The data included new results on the magnitude of benefit seen in children receiving VOXZOGO, including statistically significant improvements in annualized growth velocity (AGV), standing height, height Z-score and arm span after 52 weeks, with safety findings consistent with the established profile of VOXZOGO in achondroplasia.
The CANOPY-HCH-3 study showed that treatment with VOXZOGO led to a statistically significant improvement in AGV compared with placebo after 52 weeks, meeting the study's primary endpoint (least squares [LS] mean difference of 2.33 cm/year; p<0.0001). Children treated with VOXZOGO also showed significant improvements in standing height (LS mean difference of 2.35 cm; p<0.0001), height Z-score (LS mean difference of 0.39 standard deviation score; p<0.0001), and arm span (LS mean difference of 1.03 cm; p=0.0082) compared with placebo. Children who received VOXZOGO also demonstrated numerical improvements in quality of life, and follow-up will continue to assess the impact of treatment over a longer term. The overall safety profile was consistent with previous studies of VOXZOGO, with most adverse events reported as mild and no treatment-related serious adverse events identified.
"These results presented in detail for the first time provide a comprehensive picture of the impact of VOXZOGO across multiple measures of growth in children with hypochondroplasia," said Greg Friberg, M.D., Executive Vice President and Chief Research & Development Officer at BioMarin. "Based on this compelling body of evidence, we have submitted these data to the FDA with the goal of securing approval for the first medicine for children with hypochondroplasia."
"Hypochondroplasia can affect a child's growth, physical function and everyday life, with families often navigating unique challenges as they support their children's development," said Andrew Dauber, M.D., lead study investigator and Chief of Endocrinology at Children's National in Washington, D.C. "The changes we observed in annualized growth velocity and arm span provide encouraging evidence of how children with hypochondroplasia responded to treatment throughout the study. These findings deepen our understanding of the condition while reinforcing VOXZOGO's potential as the first targeted medicine developed specifically for children with hypochondroplasia."
BioMarin recently submitted its supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the approval of VOXZOGO for the treatment of hypochondroplasia and are on track with the submissions to the European Medicines Agency (EMA) and other regional health authorities. If approved, VOXZOGO would be the first targeted therapy for the treatment of hypochondroplasia, with a potential 2027 launch.
Below are key BioMarin presentations across both achondroplasia and hypochondroplasia at ESPE, with all times listed in Central European Summer Time:
Vosoritide Increases Growth Velocity in Children With Hypochondroplasia: Phase 3 Trial Results
Oral Presentation #LBA 1067
Wednesday, Sept. 9, 10:48 – 10:56 a.m.
Vosoritide Safety and Effectiveness in Young Children With Achondroplasia Aged ≤3 Years and With up to 36 Months of Follow-Up from the Japanese Post-Marketing Safety Surveillance Study (111-604)
Oral Presentation #FC3.4
Tuesday, Sept. 8, 3:30 – 3:40 p.m.
About Hypochondroplasia
Hypochondroplasia is a rare, genetic skeletal dysplasia characterized by impaired bone growth, leading to disproportionate short stature and skeletal differences that can affect the long bones, spine and other parts of the skeleton and may impact physical functioning and overall quality of life. The condition presents with a broad and variable clinical spectrum and may include otolaryngologic (related to the ears, nose and throat) and neurological complications and is often diagnosed in toddlerhood or early school age based on clinical and radiological findings. BioMarin estimates that roughly 14,000 children with hypochondroplasia within the company's global footprint may be eligible for treatment with VOXZOGO.
There are currently no medicines approved by the U.S. Food and Drug Administration or the European Medicines Agency for the treatment of hypochondroplasia.
For more information about our clinical trials in hypochondroplasia, achondroplasia and other skeletal conditions, please visit clinicaltrials.biomarin.com.
About VOXZOGO
In children with achondroplasia, endochondral bone growth, an essential process by which bone tissue is created, is negatively regulated due to a gain of function mutation in FGFR3. VOXZOGO, a C-type natriuretic peptide (CNP) analog, acts as a positive regulator of the signaling pathway downstream of FGFR3 to promote endochondral bone growth.
VOXZOGO is the only approved medicine to support the growth of children with achondroplasia starting from birth, with international consensus guidelines recommending initiation of VOXZOGO as early as possible. First approved in 2021, VOXZOGO has helped more than 5,000 infants and children in more than 50 countries. Through our ongoing studies, BioMarin continues to evaluate VOXZOGO on key clinical endpoints relevant for achondroplasia patients, such as arm span, tibial bowing (leg bowing), body proportionality, spinal morphology (including spinal stenosis) and quality of life measures.
VOXZOGO is approved in the U.S., Japan and Australia to increase linear growth in children of all ages with achondroplasia with open epiphyses, and VOXZOGO is indicated in the EU for the treatment of achondroplasia in children 4 months of age and older whose epiphyses are not closed, as confirmed by appropriate genetic testing. In the U.S., this indication is approved under accelerated approval based on an improvement in annualized growth velocity. Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trial(s). An sNDA with long-term safety and efficacy data from three ongoing studies, including adult height and additional clinical outcomes beyond linear growth such as body proportionality and arm span is under review with an FDA Prescription Drug User Fee Act (PDUFA) target action date of Feb. 28, 2027.
The use of VOXZOGO to treat hypochondroplasia has not yet been approved by any regulatory agency.
VOXZOGO U.S. Important Safety Information
What is VOXZOGO used for?
VOXZOGO is a prescription medicine used to increase linear growth in children with achondroplasia and open growth plates (epiphyses). VOXZOGO is approved under accelerated approval based on an improvement in annualized growth velocity. Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trials. What is the most important safety information about VOXZOGO?
VOXZOGO may cause serious side effects including a temporary decrease in blood pressure in some patients. To reduce the risk of a decrease in blood pressure and associated symptoms (dizziness, feeling tired, or nausea), patients should eat a meal and drink 8 to 10 ounces of fluid within 1 hour before receiving VOXZOGO. What are the most common side effects of VOXZOGO?
The most common side effects of VOXZOGO include injection site reactions (including redness, itching, swelling, bruising, rash, hives, and injection site pain), high levels of blood alkaline phosphatase shown in blood tests, vomiting, joint pain, decreased blood pressure, and stomachache. These are not all the possible side effects of VOXZOGO. Ask your healthcare provider for medical advice about side effects, and about any side effects that bother the patient or that do not go away. How is VOXZOGO taken?
VOXZOGO is taken daily as an injection given under the skin, administered by a caregiver after a healthcare provider determines the caregiver is able to administer VOXZOGO. Do not try to inject VOXZOGO until you have been shown the right way by your healthcare provider. VOXZOGO is supplied with Instructions for Use that describe the steps for preparing, injecting, and disposing VOXZOGO. Caregivers should review the Instructions for Use for guidance and any time they receive a refill of VOXZOGO in case any changes have been made. Inject VOXZOGO 1 time every day, at about the same time each day. If a dose of VOXZOGO is missed, it can be given within 12 hours from the missed dose. After 12 hours, skip the missed dose and administer the next daily dose as usual. The dose of VOXZOGO is based on body weight. Your healthcare provider will adjust the dose based on changes in weight following regular check-ups. Your healthcare provider will monitor the patient's growth and tell you when to stop taking VOXZOGO if they determine the patient is no longer able to grow. Stop administering VOXZOGO if instructed by your healthcare provider. What should you tell the doctor before or during taking VOXZOGO?
Tell your doctor about all of the patient's medical conditions including If the patient has heart disease (cardiac or vascular disease), or if the patient is on blood pressure medicine (anti-hypertensive medicine). If the patient has kidney problems or renal impairment. If the patient is pregnant or plans to become pregnant. It is not known if VOXZOGO will harm the unborn baby. If the patient is breastfeeding or plans to breastfeed. It is not known if VOXZOGO passes into breast milk. Tell your doctor about all of the medicines the patient takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. You may report side effects to BioMarin at 1-866-906-6100. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see additional safety information in the full Prescribing Information and Patient Information.
About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit www.biomarin.com.
Forward-Looking Statements
This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc. (BioMarin), including without limitation, statements about: the data to be presented at European Society for Paediatric Endocrinology (ESPE) 2026 Annual Meeting, including the safety profile and potential benefits of VOXZOGO for children with hypochondroplasia and achondroplasia; BioMarin's plans and expectations for the development of VOXZOGO for children with hypochondroplasia, including the expectation that, if approved by the U.S. Food and Drug Administration (FDA), VOXZOGO would be the first targeted therapy for the treatment of hypochondroplasia with a potential 2027 launch; BioMarin's expectations regarding its supplemental New Drug Application (sNDA) for VOXZOGO for full approval in children with achondroplasia, including expectations regarding the Prescription Drug User Fee Act (PDUFA) target action date; and BioMarin's estimate regarding total addressable patient population (TAPP) with respect to the conditions targeted by BioMarin's product candidates and commercial products, including hypochondroplasia. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others, results and timing of current and planned preclinical studies and clinical trials and the release of data from those trials; any potential adverse events observed in the continuing monitoring of the patients in the clinical trials; the content and timing of decisions by the FDA, the European Medicines Agency, the European Commission and other regulatory authorities; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission (SEC), including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, as such factors may be updated by any subsequent filings with the SEC. Investors are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.
BioMarin® and VOXZOGO® are registered trademarks of BioMarin Pharmaceutical Inc.
KENNEDY SPACE CENTER, Fla.--(BUSINESS WIRE)--Starfighters Space, Inc. (“Starfighters” or the “Company”) (NYSE American: FJET), the space company operating the world's only commercial fleet of flight-ready Mach 2+ supersonic aircraft, and Vaya Defense & Space, Inc. (“Vaya”), a privately held developer of the patented Vortex-Hybrid rocket engine, today announced entering into a memorandum of understanding (MOU) to explore collaboration on supersonic captive-carry flight testing and air-launch.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Space Exploration Technologies (SPCX -2.29%) stock is not off to a great start. Although the stock soared in its first week of trading, at this writing it's 27% off its high and trading below its first-day opening price.
There's a lot to like about SpaceX, and the company is just getting started in its three businesses: rocket launching, satellite broadband, and artificial intelligence (AI). If you have $5,000 to invest, here's how much it might be worth in 2031.
Image source: Getty Images.
SpaceX is much more than space SpaceX is known for its rocket-launching business that brings space exploration to new levels. It's perfecting its reusable rocket technology, which should make the process more affordable and increase access to space travel. It sends rockets to bring satellites into space, and it also works with private clients, including the U.S. government. It already has 78 launches year to date as of the end of the second quarter.
Starlink is its satellite broadband business, and it's the largest of its kind. It has 10,200 satellites in orbit and serves 12 million customers in 167 countries.
Finally, it merged with Elon Musk's xAI earlier this year, rounding out its business portfolio. xAI makes money by selling data center space to cloud companies and through its large-language model (LLM), Grok.
The first two businesses have a strong connection, and both are based around some kind of space technology. xAI fits in more tangentially, as Musk envisions sending data centers into space to be powered by the sun.
The company as a whole delivered strong performance in the 2026 second quarter, its first as a public company. Revenue increased 92% year over year, a smashing opening, and net loss improved from $1 billion to $541 million. Space revenue increased 29%, but it's still not profitable. The company is investing in research and development, which it believes will eventually lead to a 99% reduction in costs from the historical average, as well as expand its market opportunity.
Starlink revenue was up 66% over last year, and operating income increased 79%. Starlink is way ahead of any competition, and customer count doubled year over year.
Finally, AI sales were up 247% over last year, although its dragging down total profitability; Operating loss was $1.3 billion. This is where the company is spending, and capital expenditures were $15.8 billion in the second quarter. It makes sense, considering that this is where management sees its greatest opportunities.
What could happen over the next five years Wall Street expects revenue to 137% in 2027, an acceleration from today's already phenomenal rates. Analysts are looking for $39 billion in full-year revenue for 2026, which makes SpaceX a fairly small company. Tesla, for example, Musk's original company, has $103.6 billion in trailing 12-month revenue.
Today's Change
(
-2.29
%) $
-3.52
Current Price
$
149.96
Here are a few options for how much revenue SpaceX might have in 2031, based on different compound annual growth rates (CAGR):
100%: $1.25 trillion 50%: $296 billion 30%: $144.8 billion That's quite a range. The 100% rate doesn't seem plausible, but if you assume a 50% CAGR, keeping the price-to-sales ratio of 69 constant, the market cap would exceed $20 trillion. That seems hard to believe, and you have to assume the ratio will come down. If it's halved, the market cap would still be an eye-raising $10 trillion, although that's more reasonable for five years from now.
I would say that's the best-case scenario, and it implies the stock gaining 500% from nearly $2 trillion today. If it happens, your $5,000 would be worth $25,000. More realistically, though, I think the ratio will come down further, and the CAGR is likely to as well. Using 20 as a more reasonable price-to-sales estimate with a 50% CAGR, SpaceX stock would be worth $5.9 trillion, and your $5,000 investment could be worth $15,000. At a 30% CAGR, the market cap would be only $2.9 trillion, and your investment would be worth $7,250. Keep in mind that SpaceX is fairly risky today, since it isn't profitable, and the end result could be very different from what came out of this exercise.
Tim Cook called it a hundred-year flood in memory pricing, and now Apple is betting a $2,400 foldable iPhone can keep margins intact while rivals have already lapped the category twice.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Apple’s (NASDAQ:AAPL | AAPL Price Prediction) product event lands tomorrow, and the story ahead of it has less to do with hardware romance than with margin arithmetic. On September 8, 2026, CNBC reporter MacKenzie Sigalos previewed a lineup she framed as a deliberate push upmarket, anchored by a foldable device reportedly called iPhone Ultra.
Apple enters the event with supportive fundamentals. The stock closed at $316.22, up 33.43% over the past year, and last quarter it reported $109.4 billion in revenue with company gross margin at 50.1%.
But those numbers arrive alongside a candid warning from Tim Cook about “a 100-year flood on the memory pricing”. Read the foldable as the response, and the event becomes a test of whether pricing power can carry the P&L while unit growth stays modest.
What Sigalos Says to Expect Sigalos told CNBC viewers that Apple is expected to skip a regular iPhone 18 and lean into a foldable that would, per Sigalos, represent the first major iPhone design change in nearly a decade.
According to Sigalos, the iPhone Ultra is expected to start around $2,400 and top $3,000 at higher storage tiers. Early production is reportedly very limited, which Sigalos suggested could feed scarcity-driven demand.
She also cited a Morgan Stanley projection of $14 billion in December-quarter revenue tied to the foldable alone, according to CNBC. That figure remains a projection that depends on Apple hitting an aggressive ramp on a first-generation product.
A new A20 Pro chip is also expected, aimed at running more of Siri on device, according to CNBC. None of this is confirmed by Apple; treat every specification, price, and ship window as reported expectation until the keynote.
Pricing Architecture and the ASP Lever Average selling price is the quiet variable that decides how this quarter looks. If mix shifts toward a $2,400 tier, iPhone revenue can grow even if the unit count barely moves, according to CNBC.
That matters because iPhone was $54.3 billion of last quarter’s revenue, still Apple’s biggest single line. A blended ASP lift compounds directly through a product’s gross margin that already ran at 40.1%.
Sigalos summarized the playbook plainly: push the mix toward more expensive devices, lift ASPs, and protect margins even with modest unit growth. Analyst models agree the top line has room to run, with the FY2027 revenue consensus at $526.35 billion.
The risk is that borrowed growth today makes next year’s comparison harder, an issue Apple has managed before but never at this price ceiling.
Passing Memory Costs to the Consumer Cook already told investors Apple “reluctantly raised prices” because memory inflation was outrunning the company’s ability to absorb it. Sigalos reported that the street expects like-for-like price increases of $200 to $500 versus comparable iPhone 17 models.
Apple’s most recent 8-K shows why the pass-through matters: gross profit rose to $54.77 billion, and management flagged that memory costs will step higher again in the September quarter.
Charging consumers instead of eating the cost protects reported margin, but it strains the value proposition at the low end of the Pro line. Buyers, however, have real alternatives, including holding their current phone another year.
Cook was unusually direct about evaluating units, revenue, and margin together rather than optimizing any single line.
Competitive Pressure and the iPhone 17 Comp Problem, according to CNBC Huawei and Xiaomi have sold foldables for years, particularly in Greater China, where Apple’s segment revenue was $18.82 billion last quarter. Apple is arriving late to a category rivals have already iterated through multiple generations.
Sigalos also flagged that Apple faces tougher iPhone 17 comparisons after that lineup drove 22% year-over-year iPhone growth. Lapping that result with a supply-constrained foldable is a demanding setup.
Services growth is also cooling, with the segment up 12% from a year ago at $30.7 billion, pressured by foreign exchange and App Store rule changes. A foldable buyer typically converts to higher iCloud and AppleCare spend, which helps explain the $2,400 anchor.
Retail sentiment reflects the ambivalence: Reddit’s most-upvoted AAPL thread this week asked whether a $2,500 foldable iPhone is really enough to move the stock.
Is AAPL Stock a Buy? At a 41x trailing P/E and 2.14% free cash flow yield, Apple is priced for the pricing strategy to work. The margin math is defensible; the comparison math is the harder problem heading into FY2027.
Trading volume for price can hold for a cycle or two, especially with Services attach economics behind it, although it does borrow growth from later years if memory costs normalize and buyers resist another hike.
Given the defensive margin profile, the buyback pace of $62.09 billion over nine months, and neutral-to-positive sentiment at a composite 54.2, the risk/reward looks balanced heading into the event, with the setup skewed toward waiting to digest the keynote before adding exposure. I’d tag it a hold, as Apple is undergoing a transition with its new CEO.
Contact [email protected] for any questions or corrections.
Crude oil hit $95 for the first time in three months as overnight strikes on oil tankers from Iranian forces demonstrates longevity in the U.S.-Iran war. Kevin Green details what he believes will happen with oil prices and tells investors to brace for further volatility.
Not financial or tax advice. PANews content is strictly educational and informational and is not investment advice, financial advice, tax advice, legal advice, or a solicitation to buy or sell any digital asset, security, or financial product. Do your own research and consult qualified advisers.
Disclosure. PANews may publish sponsored content, partner content, advertisements, affiliate links, event promotions, and market commentary involving Web3 projects, service providers, or financial products. PANews personnel, contributors, or affiliates may hold digital assets or other interests related to covered topics. See our Terms of Service.
Apple (AAPL -0.46%) has been a quiet outperformer this year. It has risen around 18% this year, while the S&P 500 (^GSPC -0.31%) is up around 13%. That's a solid outperformance, but what investors are focused on is what happens over the next year. Apple has some major headwinds popping up, and with new CEO John Ternus at the helm, he's going to be thrown into the deep end quickly.
I think this could be a problematic run for Apple, and if you own shares, now may be the time to exit.
Image source: The Motley Fool.
Apple is highly valued for its growth If you compare Apple stock to its peers, it's clear that it has a much greater premium than any of them.
NVDA P/E Ratio (Forward) data by YCharts
Apple is in a league of its own and must maintain consistent execution if it hopes to stay on top. The problem is, a storm is coming.
During Tim Cook's last earnings call as CEO, he noted a particular problem that could cause issues: memory chip prices. AI firms have eaten up all available memory chip capacity, which is causing prices to skyrocket for these components. Apple isn't immune to these price increases, so it has two choices: First, it can eat the price increase, which cuts into profits. Second, it can raise prices on devices to compensate. The second option could push consumers who are already stretched to the brink, potentially leading them to delay an upgrade or switch to a different phone provider. Regardless, it isn't an easy situation for a new leader to find himself in, which is why Cook framed the event as a "100-year flood."
Premium Feature
Moneyball Superscore
88/100
Today's Change
(
-0.46
%) $
-1.46
Current Price
$
314.76
I think all of this could negatively affect Apple's stock and force the market to value Apple at a more reasonable level. With its big tech peers all growing faster, I think there's a tough case for Apple to maintain its premium valuation.
NVDA Revenue (Quarterly YOY Growth) data by YCharts
Should Apple fall to a big tech average valuation of 25 times forward earnings, combined with fiscal-year 2027's projections (Wall Street analysts estimate $9.57 in earnings per share next year), that would price the stock at about $240 per share. That's a long way down from today's $320 stock price, but I don't think it's out of the question.
The reality is that Apple is a very expensive stock with a valuation out of sync with other big tech peers despite a slower growth rate. Weakness in sales due to price hikes or shrinking margins could trigger a drop, making Apple a poor stock to own over the next year.
Keithen Drury has positions in Alphabet, Amazon, Microsoft, and Nvidia. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Microsoft, and Nvidia. The Motley Fool has a disclosure policy.
HONG KONG, September 8th, 2026 — Liquidity Arena 2026, an AI quantitative trading competition organized by global institutional prime broker LTP, will enter its dual-track main competition on September 9, bringing together AI developers, research teams, hedge funds, proprietary trading firms, high-frequency trading teams, and professional traders.
The competition has attracted more than hundreds of teams across its two tracks. During Track A Phase 1, held from July 20 to August 21, participating AI agents executed more than 70,000 trades. Thirty teams advanced to the final stage.
Two Tracks, Different Measures of Trading PerformanceBeginning September 9, Liquidity Arena will run two distinct tracks designed for different types of trading talent and strategies.
Track A — Logic FrontierTrack A enters its final stage with the 30 teams that advanced from Phase 1.
Designed for AI developers, agent builders, universities, research labs and professional traders, Logic Frontier goes beyond conventional PnL-based competition. Teams are required to use LTP’s RapidX environment, while the competition incorporates MCP-based Reasoning Log verification to examine how autonomous agents interpret market information and make trading decisions.
The competition therefore evaluates not only trading outcomes, but also the reasoning quality, consistency and market interpretation behind those decisions.
The core question is no longer simply who makes the most money? — but how reliably can an autonomous trading system reason and perform under changing market conditions?
Track B — Liquidity ProLaunching on September 9, Track B is designed for hedge funds, proprietary trading firms, HFT teams and professional traders.
Liquidity Pro puts the emphasis on performance, capital capacity, execution quality and slippage control. Teams can deploy their strategies through flexible trading infrastructure, including DMA, RapidX and other supported venues.
The objective is straightforward: prove that a strategy can perform effectively in live market conditions while managing execution and scale.
Registration for Track B remains open until 23:59 GMT+8 on September 23, 2026.
More Than $300,000 in Total Prize ValueLiquidity Arena 2026 features a total prize pool of more than $300,000, combining cash rewards with AI incentives, institutional trading benefits, partner products and career opportunities.
The reward structure includes:
$100,000+ in cash prizes for the top three teams in each track
AI agent credits and token incentives to support AI usage and reward outstanding performance
LTP VIP trading tiers and clearing-fee benefits for eligible teams after the competition
Products and benefits from sponsors and ecosystem partners
Career opportunities, including internship opportunities from LTP and additional opportunities from partners
The goal is to create a reward ecosystem that extends beyond the competition itself — giving high-performing teams access to capital-efficient trading infrastructure, technology, ecosystem resources and potential career opportunities.
Institutional-Grade Infrastructure and Global EcosystemLiquidity Arena is organized by LTP, with AWS and Calais serving as co-organizers. MiniMax, SoSoValue and AIVIX support the competition across AI, market data and analytics. 1ndex by 1Token serves as an Ecosystem Engine Partner, while Amsterdam Investment Club and THEO QUANT are Community Partners.
The competition is also supported by more than 20 academic and institutional partners and more than 20 media partners.
During the competition, LTP provides the institutional-grade trading infrastructure and operational support for participating teams. Teams will test and evaluate their strategies in trading environments designed to reflect market conditions, where performance is influenced not only by theoretical returns or backtested results, but also by liquidity, execution quality and slippage.
For AI-focused teams, the environment provides a setting to evaluate autonomous reasoning and decision-making in financial market scenarios. For professional quantitative teams, it provides a framework for assessing strategy performance under practical considerations, including capital scale, market impact and execution costs.
About LTPLTP is a global institutional prime broker, purpose-built to meet the evolving needs of digital asset market participants. By applying traditional financial standards to blockchain innovation, LTP provides end-to-end prime services spanning trade execution, clearing, settlement, custody, and financing. Its offerings further extend to institutional asset management, regulated OTC block trading, and compliant on/off-ramp solutions — delivering a secure and scalable foundation for institutions across the digital asset ecosystem.
The Group operates under a multi-jurisdictional regulatory framework, holding licenses and registrations in Hong Kong, Australia, the United Arab Emirates, and the British Virgin Islands, among other jurisdictions, enabling it to serve institutional clients globally on a compliant basis.
Brain-computer interfaces have largely been associated with Elon Musk‘s Neuralink and its implantable chips. But Apple Inc‘s (NASDAQ:AAPL) quiet acquisition of startup Sonera suggests the iPhone maker is pursuing a similar long-term ambition through a very different route: bringing brain and muscle sensing to consumer wearables rather than the operating room.
Apple’s Brain Tech BetApple acquired California-based startup Sonera in May, according to newly disclosed European Union filings. The startup developed compact magnetic sensors capable of detecting tiny magnetic fields generated by the brain and muscles without requiring skin contact or implanted devices.
Founded by UC Berkeley researchers Nishita Deka and Dominic Labanowski, Sonera initially focused on muscle monitoring before expanding into technology that could eventually enable everyday brain sensing. The company’s website has since gone offline following the acquisition.
Apple has not publicly disclosed how it plans to use the technology, but the acquisition aligns with the company’s broader push into digital health, accessibility and more natural ways for users to interact with its devices.
Read Next
Neuralink’s Different PathThe comparison with Neuralink is inevitable, but the two companies appear to be solving different parts of the same problem.
Neuralink is developing implantable brain-computer interfaces designed to capture high-fidelity neural signals, with an initial focus on helping people with severe neurological conditions regain communication and physical control.
Apple’s approach, by contrast, appears to prioritize accessibility and scale. If non-invasive sensors become sufficiently accurate, they could eventually be integrated into products such as the Apple Watch, Vision Pro or other wearable devices, enabling new forms of gesture recognition, health monitoring or hands-free interaction without surgery.
That distinction reflects a broader trade-off in brain-computer interfaces: implanted devices can capture richer neural data, while wearable sensors have the potential to reach hundreds of millions of consumers if the technology matures.
What Investors Should WatchApple’s acquisition of Sonera does not mean brain-controlled consumer devices are around the corner. Non-invasive sensing remains an emerging technology, and the company has yet to reveal any commercial roadmap.
The bigger takeaway is strategic. Apple has consistently expanded its ecosystem by bringing advanced health technologies—from heart rhythm monitoring to hearing health—into everyday consumer devices.
If brain and muscle sensing follows a similar path, the acquisition could represent an early investment in what may become the next generation of human-device interaction, even if Apple’s route looks very different from Musk’s Neuralink.
Dominic Rizzo, T. Rowe Price Global Technology Fund portfolio manager, joins 'Squawk Box' to discuss Apple's expected unveiling of the iPhone 18, what the release means for Apple, and more.
Apple (NASDAQ: AAPL) unveiled the iPhone Air and broader iPhone 17 lineup at its September 2025 launch event, kicking off a product cycle that helped drive the company’s shares sharply higher over the following year.
Since the event on September 9, 2025, Apple stock has climbed from about $233 to $316, a gain of roughly 35.6%.
Apple stock price chart. Source: Finbold As a result, a $1,000 investment made on the day of the launch would now be worth approximately $1,356, excluding dividends.
Apple’s successful product roll-out The rally coincided with a successful rollout of the iPhone 17 family, including the iPhone 17, iPhone 17 Pro, iPhone 17 Pro Max, and ultra-thin iPhone Air. Strong demand boosted upgrade rates and helped accelerate growth throughout fiscal 2026.
That momentum was reflected in Apple’s fiscal Q3 2026 results. The company reported record June-quarter revenue of $109.42 billion, up 16.4% year over year.
iPhone revenue rose 21.7% to $54.3 billion, while Mac revenue increased 28.7% to $10.4 billion. Services revenue reached a June-quarter record of $30.74 billion, helping lift net income 27% to $29.8 billion. Diluted EPS came in at $2.02, ahead of analyst estimates of $1.89.
At the same time, the technology giant’s pricing power also supported results. Despite higher memory costs, the company adjusted prices on select products and guided for September-quarter revenue growth of 9% to 11% and gross margins of 47% to 48%.
Long-term growth drivers remain intact with Apple’s silicon strategy continuing to deliver performance and efficiency advantages, while Services has evolved into a high-margin business generating more than $120 billion in trailing 12-month revenue.
Apple 2026’s Event Investor sentiment has also been supported by expectations for future products under CEO John Ternus.
Anticipation surrounding Apple’s first foldable iPhone and other premium devices has helped sustain interest in the stock, even as component shortages and elevated memory costs created periodic volatility.
The focus now shifts to Apple’s September 9, 2026, event, titled “Surprise and Shine,” the first major product presentation under Ternus after succeeding Tim Cook on September 1.
Apple is expected to unveil the iPhone 18 Pro and iPhone 18 Pro Max powered by the A20 Pro chip, alongside its long-awaited foldable iPhone.
Updated Apple Watch Series 12 and Ultra 4 models are also anticipated, while the standard iPhone 18 lineup is reportedly being pushed to spring 2027 as part of a strategy focused on higher-margin products.
Featured image via Shutterstock
Best Crypto Exchange for Intermediate Traders and Investors
Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.
0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.
Copy top-performing traders in real time, automatically.
eToro USA is registered with FINRA for securities trading.
30+ million Users worldwide
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD
Join Finbold's newsroom, become a Sales Executive today! Apply now to join Finbold as a crypto/finance news writer!
As Apple prepares to unveil its most ambitious iPhone in years, veteran tech analyst Paul Meeks is raising a quiet alarm about a supplier oligopoly that could turn a blockbuster launch into a margin nightmare.
Just before Apple (NASDAQ:AAPL | AAPL Price Prediction) takes the stage for what Bloomberg’s Mark Gurman calls “the most exciting iPhone launch in a decade”, others are less convinced. Veteran tech analyst Paul Meeks of Freedom Capital Markets used a CNBC appearance to push back on the celebration. His message: the memory oligopoly is quietly winning this cycle, and Apple’s gross margins will pay for it.
Meeks warned viewers not to get swept up in the hype around the debut of the first foldable iPhone, codenamed V68, expected to start near $2,000 and unveiled by incoming CEO John Ternus. “I’m afraid…that you might be overselling it,” he said, flagging Apple’s lagging AI position as a structural concern.
Meeks’s Memory Warning, In His Own Words Meeks identified the mechanism squeezing Apple: an entrenched supplier oligopoly. He called out the “big three oligopolies in memory,” Micron, SK Hynix, and Samsung, controling roughly 90% of market share, adding:
“A company with the heft of an Apple has to pay more. Cost of goods sold goes up, gross margins go down. And it’s a real problem.”
Former CEO Tim Cook confirmed the pressure on Apple’s Q3 FY26 call. He described the environment as “a 100-year flood on the memory pricing with exponential increases in memory prices” and said Apple “reluctantly raised prices.” CFO Kevan Parekh added that “more than 100% of that can be explained by the memory cost change” when explaining sequential margin compression.
Fundamentals Still Look Strong The warning lands against a genuinely powerful backdrop. Apple posted June-quarter revenue of $109.42 billion, up 16.4% YoY, with EPS of $2.02 beating consensus by 6.80%, the ninth straight upside surprise. iPhone revenue reached $54.25 billion and Services hit $30.74 billion. The stock trades at $315.49, up 34.62% over one year, with a market cap of $4.61 trillion and a trailing P/E near 37.
But Cook flagged that “for September, we expect to pay even higher memory costs.” He further warned supply constraints will affect iPhone, Mac, and iPad. September-quarter gross margin guidance sits at between 47% and 48%, with roughly a point of that from tariff refunds.
Where the Money Went Meeks’s data point is Micron Technology (NASDAQ:MU), the U.S. memory maker riding the same wave that is pinching Apple. Micron shares trade at $1,0001, up 640.4% over one year and 250.8% year to date. Fiscal Q3 revenue reached $41.46 billion, up 345.7% YoY, with gross margin of 84.6%. CEO Sanjay Mehrotra said record results “reflect the strategic value of memory in the AI era.”
Meeks expects the squeeze to persist, forecasting no relief in memory pricing for years. He points capital toward AI data-center names including CoreWeave, Applied Digital, and NVIDIA (we profiled seven suppliers powering that same buildout, from power to cooling, in a free AI infrastructure report). Investors watching today’s launch should keep an eye on the stock, but also on Apple’s next margin commentary.
Contact [email protected] for any questions or corrections.
In recent years, Apple has become known as a safe AI stock that’s rarely recognized as an AI stock. The firm’s measured adoption of cutting-edge technologies means there are no first-mover advantages, but the artificial intelligence boom was never meant to be a sprint.
We’re about to see Apple (NASDAQ:AAPL) enter a brave new world under the leadership of incumbent CEO John Ternus.
At Apple’s upcoming launch event, the headline-maker appears to be the arrival of the smartphone giant’s first-ever foldable iPhone, but it’s likely to be the firm’s statements on AI that carry the biggest impact.
Given that there has been very little of the seismic capex deployed by the AI hyperscalers that populate the Magnificent Seven, Apple has an opportunity to manage a far more measured AI rollout that paves the way for sustainable growth on Wall Street. But what does adoption look like under Ternus’ leadership? Let’s take a deeper look at how Apple can strategize being a late mover in the artificial intelligence boom:
AI Without a BuildoutCapex has increasingly entered the spotlight in 2026, with Magnificent Seven firms committing a combined $780 billion towards AI buildouts throughout the year.
The rate of spending has far exceeded 2025 figures already, which amounted to around $400 billion in comparison.
But Apple has remained on the sidelines as its peers have spent big. Throughout the first nine months of fiscal 2026, the company spent approximately $6.8 billion on capital expenditures, with around $14 billion projected for the full year.
It’s this cautious strategy that could pay dividends over the long term, particularly because Apple’s unique market position could enable the company to reach a massive audience without the need to construct data centers at scale.
With 2.5 billion active devices in circulation and the recently unveiled Siri AI running on custom silicon, Apple has the potential to overtake many of its peers as part of its artificial intelligence adoption cycle.
Critically, Apple has been hard at work in building integrated systems to support its AI rollout, and because the company controls its hardware, operating system, and the chips inside its devices, as well as already possessing a gigantic user base, its future artificial intelligence innovations have the potential to enter mainstream usage in a frictionless way.
Apple Intelligence is already helping to make this a reality, and while some AI tasks can run directly on its devices, more complex requests can be referred to private cloud compute servers, paving the way for faster and private iterations on AI on-device while still tapping into the cloud as and when required.
This means that Apple doesn’t necessarily have to build out AI data centers to the same extent as its rivals, allowing for a more agile approach.
While first-mover advantage counts for a lot on Wall Street, Apple may ultimately benefit from its patient approach, which has ensured that capex remains low while its rollout of AI devices stays as impactful as ever.
We will know more about Apple’s strength as an AI innovator in the coming days as we see new products enter the market, as well as find out what’s next for Siri AI and other intelligent software linked to iOS.
In a more bullish scenario, we could see the easy accessibility of Apple’s AI initiatives support personal and business use cases alike, with smart applications enhancing the capabilities of firms in different industries.
This higher level of adoption means that Apple’s second-mover advantage and sustainable approach to capex could see a target of $380 become achievable.
The recent deal with Broadcom, which will see Apple pay in excess of $30 billion for the production of more than 15 million US-made chips, is a statement of intent for the future of the stock, which is expected to enter $5 trillion market cap territory as its AI rollout gathers momentum.
As a result, AAPL is certainly a stock to track, and could offer plenty of upside for investors who have been big believers in the potential of AI but remain wary of high spending among hyperscalers.
Future AmbitionsAlthough new CEO John Ternus faces a big challenge in maintaining the progress that’s been built by his predecessors, he’s inherited a company that’s ripe for growth thanks to its measured AI buildout.
Although Apple won’t be indulging in the same big spending as its hyperscaler peers with data center construction taking center stage in the AI boom at present, there are plenty of economic moats that can easily push the firm to the forefront of artificial intelligence adoption in the months ahead.
Apple’s upcoming launch event will be a watershed moment for the stock with the expected announcement of the company’s first flip phone. But in terms of securing future growth, it will be positive remarks regarding Apple’s AI innovations that will provide the biggest hints for the stock’s long-term outlook.
Disclosure: On the date of publication, Dmytro Spilka did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer. Dmytro Spilka does not intend to make a trade in any of the securities mentioned above in the next 72 hours.
Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.
The first iPhone in 2007 mainstreamed touch-screen technology, years after it was developed. Now Apple is betting its maiden foldable phone can do the same for a format stuck in a niche despite years of efforts from Samsung and Chinese rivals like Huawei.
The foldable iPhone, expected to be unveiled at Apple's (AAPL.O) Cupertino headquarters later on Wednesday, marks one of the biggest changes to the flagship device that brings in around half of the company's revenue and has made it a global technology giant.
Despite attracting attention with their large screen size, foldable phones have only secured a single-digit percentage share of the overall global smartphone market due to trade-offs — including inferior cameras, a shorter battery life and an awkward crease at the screen center once the handsets are unfolded.
But analysts have said Apple, known for grabbing the second-mover advantage by learning from rivals' mistakes, will likely benefit from supply-chain and technological advances that have made foldables more durable and less prone to creasing.
Samsung's (005930.KS) latest Fold 8 device, for instance, features a design that has significantly reduced the crease, thanks to years of investment in the technology.
Here's a brief timeline of foldables ahead of Apple's event:
EARLY STRUGGLES, BIG SAMSUNG GOOF-UP (2018-2021)
Foldable phone concepts have been around for decades, but Chinese display maker Royole is credited with shipping the first such device in 2018. Its FlexPai phone, with a 7.8-inch outward-folding screen, was widely panned for clunky software and crude plastic hinges.
Months later, Samsung raised fresh fears about reliability and pricing with the $2,000 Galaxy Fold, the category's first mass-market product. Reviewers, including Marques Brownlee, reported broken screens, with some peeling a protective layer that resembled a screen protector but wasn't in a debacle dubbed "foldgate". Samsung delayed the launch and retrieved all sample devices.
The period also saw competing visions over the best shape for a foldable. The Galaxy Fold targeted customers with its inward-folding screen that expanded into a small tablet, while Motorola revived its iconic Razr in late 2019 with a clamshell design that folded a normal-size phone in half.
Huawei's Mate X, also released in 2019, folded outward and wrapped a single screen around the outside of the device, while Microsoft (MSFT.O) in 2020 skipped a flexible screen and joined two separate displays with a hinge in its Surface Duo. The Windows maker has since discontinued the devices.
SLOW MARCH TO MAINSTREAM (2022-2026)
Alphabet-owned Google (GOOGL.O) entered the market in 2023 with its $1,799 Pixel Fold, a passport-shaped device whose wider, shorter screen opened closer to a mini tablet. Meanwhile, Samsung and its Chinese rivals delivered steady improvements to foldables until the next big leap arrived in 2024 with tri-folds.
Huawei launched the first such device in September that year at $2,800, which could fold three ways like an accordion and became an instant best-seller. Samsung launched its own multi-folding smartphone in December 2025.
Today, Samsung leads the global foldable phone market with a share of about 40%, followed by Huawei with a 30% share, according to research firm Counterpoint.
The passport shape, meanwhile, has become a dividing line.
Google abandoned the design after 2023 while Samsung used it for one of its latest devices. Apple is expected to adopt the shape as it is geared more toward video and other media consumption rather than a taller, book-style phone built for productivity.
The passport shape's wider proportions sit closer to the native aspect ratio of most video, shrinking the black bars that frame footage on taller, book-style devices.
Analysts expect Apple's entry into the category would accelerate its growth, with IDC estimating that foldable phone shipments would increase nearly 30% this year, outperforming an estimated decline of nearly 1.4% in non-foldable smartphones.
"Apple's entry will surely increase competition at the premium end. However, foldables are still a very small part of the overall smartphone market, so there is room for the category to grow well beyond current volumes," said Tarun Pathak, research director at Counterpoint.
Apple (AAPL - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this maker of iPhones, iPads and other products have returned +3.7%, compared to the Zacks S&P 500 composite's -0.4% change. During this period, the Zacks Computer - Micro Computers industry, which Apple falls in, has gained 3%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, Apple is expected to post earnings of $1.98 per share, indicating a change of +7% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.3% over the last 30 days.
The consensus earnings estimate of $8.85 for the current fiscal year indicates a year-over-year change of +18.6%. This estimate has changed -0.2% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $9.54 indicates a change of +7.8% from what Apple is expected to report a year ago. Over the past month, the estimate has changed +0.2%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Apple.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
In the case of Apple, the consensus sales estimate of $112.84 billion for the current quarter points to a year-over-year change of +10.1%. The $477.42 billion and $518.01 billion estimates for the current and next fiscal years indicate changes of +14.7% and +8.5%, respectively.
Last Reported Results and Surprise HistoryApple reported revenues of $109.42 billion in the last reported quarter, representing a year-over-year change of +16.4%. EPS of $1.91 for the same period compares with $1.57 a year ago.
Compared to the Zacks Consensus Estimate of $108.75 billion, the reported revenues represent a surprise of +0.62%. The EPS surprise was +1.6%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Apple is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Apple. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
By You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Newly inaugurated Apple CEO John Ternus posted a cryptic teaser video ahead of Apple's product launch on Thursday. Michael Buckner/Variety via Getty Images John Ternus is stoking the hype.
The recently inaugurated Apple CEO took to X on Wednesday to post a cryptic, 14-second teaser video ahead of the company's hotly anticipated launch event this afternoon.
In the short clip, a small spotlight shines down on a dome-shaped, slightly translucent orb that X users speculated could be anything from an iPhone camera to an Apple-branded flashlight.
The teaser, the first of its kind for Apple, which typically doesn't publicize its product launches in such amorphous ways, signals a possible new, more glitzy direction Ternus intends to take the company.
Ternus officially replaced Tim Cook as CEO on September 1. Formerly a products guy, Ternus has represented Apple in numerous public speaking appearances and helped design the AirPods, among other products.
Recently, the ambiguous teaser video has become a popular method for tech companies to garner publicity for upcoming product launches. This summer, Samsung previewed a new line of foldable phones with a video of someone cutting a pizza.
Apple is widely expected to unveil a foldable iPhone during Wednesday's launch.
Business Insider is set to live blog the launch event from gavel to gavel. Check back on the website at 1 p.m. ET for more updates.
Read next
Truman Dickerson You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Truman Dickerson is the Weekend News Fellow at Business Insider, based in New York City. He covers trending tech and business news. He previously reported for The Boston Globe's Express Desk. He graduated from Boston University, where he served as editor in chief of The Daily Free Press, BU's student-run newspaper.Contact him at [email protected]
Apple Inc. (NASDAQ:AAPL) holds its biggest event of the year Wednesday at 1 p.m. ET at the Steve Jobs Theater in Cupertino, and for the first time in 15 years, someone other than Tim Cook will run the show.
The “Surprise and Shine” event marks the first iPhone launch under new CEO John Ternus, who took over Sept. 1 as Cook shifted into the executive chairman role.
Three new phones are expected, led by Apple’s first foldable iPhone, likely priced from $2,099 and branded “Fold” or “Ultra.” Pro-line models should see $150 to $200 price hikes tied to rising memory costs, according to Bank of America, and a revamped Siri AI, built partly on a customized Google Gemini model, rounds out the software story.
Twenty Years of Launch-Day JittersHistory suggests the stock will not celebrate right away. Across 24 iPhone launches since 2007, Apple shares have averaged a 0.3% decline on launch day itself, with a median drop of 0.6%.
The next session tends to look better: shares rose 15 of those 24 times, averaging a 0.5% gain, while the S&P 500 closed higher the day after 79.2% of the time and the Nasdaq 100 did so 75% of the time.
Wall Street Split: Buy Vs. UnderweightWall Street remains split on where Apple’s stock goes from here. Bank of America rates shares a Buy with a $380 target, implying 18.8% upside and valuing the stock at 37 times its 2027 earnings estimate, above the five-year median of 27 times.
Read Next
KeyBanc holds an Underweight rating and a $250 target, flagging roughly 80 million iPhone 18 builds through early fiscal 2027 versus 91 million a year earlier, since no base iPhone 18 model ships this cycle.
The broader analyst consensus is a Buy, with an average target of $335 across 29 analysts, about 5.4% above current levels, according to Benzinga data.
Apple shares closed Tuesday at $316.22, down 1.17%, after touching a recent high last week before sliding 2.51% Friday. The stock is up 16.68% year to date and 34.93% over the past year heading into Ternus’s first turn on the big stage.
AAPL Stock Price Activity: Apple shares were up 0.35% at $317.32 on Wednesday, according to Benzinga Pro data.
Read Next
Photo: Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
Apple's new CEO John Ternus faces his first real test before he has even settled in, as customers weigh whether to absorb two price increases inside two weeks or simply sit out the upgrade cycle entirely.
Apple (NASDAQ:AAPL | AAPL Price Prediction) is asking customers to pay more on two fronts inside a fortnight, and the second raise arrives today. Apple stock trades at $316.06, down 0.1% in Wednesday morning trading, and it’s up 17% year to date.
Two broad benchmarks are drifting alongside the launch. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) trades at $763.94, down 0.3%. Meanwhile, the Invesco QQQ Trust (NASDAQ:QQQ) sits at $718.29, practically unchanged.
Two Price Hikes in Two Weeks Apple raised the U.S. Apple TV subscription to $14.99 a month from $12.99, per a MacRumors report dated August 28. Today’s product event is expected to widen the hardware ask, with CNBC’s MacKenzie Sigalos reporting the Street looks for like-for-like iPhone price increases of $200 to $500 versus comparable iPhone 17 models.
Former CEO Tim Cook had framed the hardware repricing as forced by supply-chain math on Apple’s fiscal Q3 2026 call, saying Apple “reluctantly raised prices” because of a “100-year flood on the memory pricing.” Apple posted revenue of $109.42 billion, up 16.4% year over year, with iPhone revenue of $54.3 billion and Services of $30.7 billion.
The Bundle Took a Raise, Too The streaming increase didn’t travel alone. Apple One Individual went to $21.95 a month from $19.95 on the same day, since the bundle carries Apple TV inside it. Apple One Family and Apple One Premier held steady that day, but only because both had already been raised in July alongside an Apple Music increase. Read across the summer and the count isn’t two price increases in a fortnight. It’s a rolling sequence that started well before the September event, with Apple One Individual the last plan to get pulled up to the new line.
The Apple TV ladder is steeper than the single step suggests. The service launched in 2019 at $4.99 a month. It moved to $6.99 in 2022, to $9.99 in 2023, to $12.99 in 2025, and now to $14.99, with the annual plan going to $119 from $99. That’s four increases against one launch price, and the U.S. wasn’t alone: Brazil, Chile and Mexico were repriced the same day, while every other market was left untouched.
The revenue lands on a delay, which matters for how fast any of this reaches the Services line. New subscribers pay the higher rate immediately, while existing subscribers are notified roughly a month before their renewal bills at the new price. That gap is also the window in which cancellations happen, so the increase gets tested by subscribers before it gets counted by Apple. Whether it holds is Ternus’s problem, not Cook’s.
Streaming Peers Face the Same Playbook Netflix (NASDAQ:NFLX) says its own hikes are landing well. Netflix Q2 2026 revenue reached $12.56 billion, up 13.4%, and Greg Peters stated “our recent price adjustments are going well on the pricing side.” Netflix stock is down 18% year to date.
Walt Disney (NYSE:DIS) leaned on the same lever, with Entertainment SVOD subscription revenue growing 15% in fiscal Q3 2026 on rate and volume. Spotify Technology (NYSE:SPOT) crossed 300 million Premium subscribers with ARPU up 7% to $5.63. Disney shares are down 8.27% year to date, and Spotify shares are down 8.93%.
What Ternus Inherits John Ternus stepped in as Apple’s chief executive on August 31, which means the streaming raise and the memory-cost reasoning both belong to Cook. What Ternus owns is execution: whether customers absorb a second increase inside two weeks or hold their current iPhone for another cycle.
Apple stock carries a P/E ratio of 41x and a market cap near $4.61 trillion, so pricing follow-through matters for the multiple. Investors can size their positions with room to add if the hardware bump sticks and its gross margin holds inside the guided 47% to 48% September-quarter range. Shareholders may want to keep an eye on whether iPhone upgrade rates cool after a $200 to $500 like-for-like step up.
Contact [email protected] for any questions or corrections.
